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This study assesses the UN Inter-agency Group for Child Mortality Estimation (IGME) 
methods of estimating the infant and neonatal mortality rates from the under-five 
mortality rates in countries affected by HIV/AIDS. It uses Botswana, Malawi and South 
Africa as case studies.   
The assessment is made by comparing the IGME results with estimates from 
projection models and empirical results computed from survey data and vital statistics 
data corrected for the level of incompleteness for the countries included in the study. In 
addition, relevant literature is reviewed in order to determine the reasonableness and 
impact (on the results produced) of the assumptions made by the method. 
The IGME method for estimating the under-five mortality rate appears to 
produce estimates that are consistent with other empirical results for South Africa over 
the period of observation and for Botswana, except between 1998 and 2002 when it 
appears to produce exaggerated results for Botswana. The under-five mortality rates of 
Malawi are consistent with other results between 1980 and 1991, although the method 
appears to understate the results of Malawi during the period of high mortality of 
children due to HIV/AIDS, that is, after 1991. The IGME method of estimating the 
infant mortality rate from the under-five mortality rate appears to be affected by 
problems in the under-five mortality rate. For example, the infant mortality rate of 
Botswana between 1996 and 2003 are inflated and those of Malawi between 1992 and 
1998 and after 2006 are underestimated, as are the under-five mortality rates in the 
corresponding periods. The method for estimating neonatal mortality produces results 
that exhibit an HIV trend and are exaggerated during the period of high mortality of 
children due to HIV/AIDS for countries having low background mortality (mortality 
due to all causes other than AIDS) and affected by HIV/AIDS, as shown in the case of 
Botswana and South Africa. The method appears to produce results that are consistent 
with empirical results determined by others for countries having high and rapidly falling 
background mortality despite being affected by HIV/AIDS, as shown in the case of 
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The level of mortality below the age of five years is an indicator of the level of 
development of a country in general and social development, such as health in 
particular. As a result, the reduction of under-five mortality has been set by the UN as 
one of the millennium development goals (MDGs). Thus countries design policies, 
implement programmes and allocate resources for reducing under-five mortality rate to 
achieve this goal. 
Vital registration is the most important source of data for measuring the level and 
trend of under-five mortality rate (Ahmad, Lopez and Inoue 2000; Hill 1991; Setel, 
Macfarlane, Szreter et al. 2007), and hence for monitoring the progress towards the 
achievement of the millennium development goal, 4. Unfortunately, vital registration 
systems are non-existent or incomplete in developing countries, especially those in sub-
Saharan Africa (Hill 1991; UNICEF, WHO, UNPD et al. 2011b). Therefore, countries 
in sub-Saharan Africa depend on data obtained from surveys for the measurement of 
under-five mortality (Mahy 2003; UNICEF, WHO, UNPD et al. 2011b). The level and 
trend of under-five mortality rates computed from different surveys vary due to 
differences in the method of computation, sources of the data and/or the quality of the 
data which cause difficulty in interpreting the trend in the under-five mortality 
(UNICEF, WHO, UNPD et al. 2007). Thus the UN Inter-agency Group for Child 
Mortality Estimation (IGME) fits a weighted regression model using the under-five 
mortality rates computed from data from different surveys and the times to which the 
estimates refer for estimating the level and pattern of the under-five mortality 
(UNICEF, WHO, UNPD et al. 2011a).  
As under-five mortality declines due to efforts by countries to improve the health 
of their population and achieve the millennium development goal 4, the concentration 
of mortality in the infant and neonatal period becomes high (Obungu, Kizito and 
Bicego 1994). Moreover, the probability of dying in the first month of life and the first 
year are higher than any subsequent month or year (Lawn, Cousens and Zupan 2005; 
Sullivan, Rutstein and Bicego 1994). Therefore, the percentage contribution of infant 
and neonatal mortality to the under-five mortality increases over time. Hence countries 











know the level and causes of infant and neonatal mortality which contribute 
substantially to the under-five mortality (WHO 2006). For that reason, countries and 
international organisations have given nearly as much attention to the level and causes 
of infant mortality as to that of the under-five mortality. 
As a result, the IGME has also developed a method for estimating the level and 
trend of infant mortality. For countries affected by HIV/AIDS the IGME estimates the 
infant mortality rate by interpolating the non-AIDS infant mortality from the non-AIDS 
under-five mortality rate using the Coale and Demeny or UN model life tables and then 
adding to this value, the HIV/AIDS infant mortality estimated by UNAIDS (UNICEF, 
WHO, UNPD et al. 2007, 2010). However, this method may not result in a reasonable 
level and pattern of infant mortality for African countries in general, and those affected 
by HIV/AIDS, in particular. This is because the AIDS cause under-five mortality (used 
for estimating the non-AIDS under-five mortality) and infant mortality estimated by the 
UNAIDS may not be necessarily correct. Further, the Coale and Demeny and UN 
model life tables are not based on the mortality experience of African countries. 
Moreover, the infant mortality rate is likely to be affected if any problem exists in the 
under-five mortality rate, since the infant mortality rate is determined from the under-
five mortality rate. 
Although the contribution of the neonatal mortality rate to the under-five 
mortality rate is also significant, less attention has been given for estimating it 
(Oestergaard, Inoue, Yoshida et al. 2011). As suggested by Martines, Paul, Bhutta et al. 
(2005) and Lawn, Cousens, Darmstadt et al. (2006), because little attention is paid to 
neonatal mortality, achieving the millennium development goal 4 could be less likely for 
most countries. As a result international organisations and countries have recently 
realised that increased attention should be given to neonatal mortality in order to reduce 
the under-five mortality and hence to achieve millennium development goal (MDG) 4. 
One of the mechanisms for increasing attention on neonatal mortality is the publication 
of estimates of neonatal mortality rates on an annual basis for each country (Lawn, 
Cousens, Darmstadt et al. 2006; Martines, Paul, Bhutta et al. 2005). Consequently 
improved methods of measuring neonatal mortality are emerging of which proposed by 
the IGME is one. 
The IGME argues that since the quality of survey data on neonatal mortality is 
poor, and hence the neonatal mortality rate has to be estimated from under-five 











decades there has been a decline in under-five mortality rates in the developing 
countries, although this has stagnated and even reversed in some countries, particularly 
in sub-Saharan region due to HIV/AIDS. However, the decline in the neonatal 
mortality as compared to the under-five mortality is slow (Dinh, Nga, Malqvist et al. 
2008; Hall 2005; Hill and Chio 2005; Hill and Pande 1997). Thus estimating neonatal 
mortality rate from the under-five mortality rate could produce incorrect estimates. 
The results determined using the IGME models are widely used by countries and 
organisations which interpret the pattern and level of the under-five, infant and neonatal 
mortality rates and hence monitor the progress towards the achievement of the MDG 4. 
However, Alkema and Ann (2011) and Murray, Laakso, Shibuya et al. (2007) question 
the reasonableness of the IGME results, especially the under-five mortality rates and 
proposed a different approach. 
This study determines the validity of the IGME methods and results by 
comparing them with other empirical estimates and assessing the consistency of the 
IGME results with the theory of the age pattern of mortality below the age of five years 
and assesses if the assumptions made by the method make sense for countries affected 
by HIV/AIDS.  
1.2 Objective of the research 
This section presents the general and specific objectives of the research. 
1.2.1 General objective of the research 
The purpose of this study is to assess the methods of estimating the infant and neonatal 
mortality rates employed by the IGME in high HIV prevalence countries using 
Botswana, Malawi and South Africa as case studies. 
1.2.2 Specific objectives of the research 
The specific objectives of the research are as follows: 
1. To understand and describe how the IGME estimate the infant mortality and 
neonatal mortality from the under-five mortality. 
2. To assess the reasonableness of neonatal and infant mortality rates computed 
from under-five mortality rate using the IGME method for the countries 
under study. 
3. To draw conclusions about the relationship between the neonatal mortality 
rate and under-five mortality rate in an HIV/AIDS epidemic and hence 











1.3 Significance of the study 
The IGME under-five, infant and neonatal mortality rates are widely used by countries 
and international organisations for determining the level and pattern of mortality below 
five years of age and hence help monitor and evaluate their policies and interventions in 
the area of health. However, Alkema and Ann (2011) and Murray, Laakso, Shibuya et al. 
(2007) question the reasonableness of the IGME under-five mortality rates. So far, no 
detailed study has been conducted validating the IGME methods of estimating the 
under-five, infant and neonatal mortality rates. This triggers, therefore, the need to 
conduct research that thoroughly assesses the reasonableness of the IGME methods 
and results, especially in countries affected by HIV/AIDS. 
This study helps to determine whether the IGME methods and results are wrong 
or correct, and helps countries and organisations have some confidence in the 
assessment of the level and trend of mortality under the age of five years and enables 
them to plan accordingly. It may also assist the IGME to revise their methods. 
1.4 Organisation of the dissertation 
This study is organised into five chapters. Chapter 2 reviews relevant literature, namely: 
the IGME methods of estimating the under-five, infant and neonatal mortality rates; 
other approaches of estimating the infant and neonatal mortality rates from the under-
five mortality rate; the age pattern of mortality below the age of five years; sources of 
data; and the method of estimating under-five, infant and neonatal mortality from 
survey and vital registration data. It also reviews the impact of HIV/AIDS on the 
methods for estimating infant and under-five mortality and the methods available for 
correcting the bias on these measures introduced due to HIV/AIDS, the impact of 
HIV/AIDS on neonatal survival and the trends in mortality measures under the age of 
five years. Chapter 3 presents the methods used to achieve the objectives of this 
research. It discusses the method of empirical and logical assessments of the IGME 
under-five, infant and neonatal mortality rates. The detailed assessment of the IGME 
methods and results are presented in Chapter 4. Chapter 5 concludes the dissertation 
with the discussion of the results, a presentation of the limitation of the research and 












2 LITERATURE REVIEW 
This chapter discusses the estimation of child mortality in general, and the estimation of 
infant mortality and neonatal mortality from under-five mortality by the IGME. Other 
approaches to estimating the neonatal and infant mortality from under-five mortality are 
also discussed. It also looks at sources of data, the methods of estimating under-five, 
infant and neonatal mortality from survey and vital registration data. Finally, it discusses 
the impact of HIV/AIDS on the estimation of under-five and infant mortality, methods 
for correcting the bias in the estimate of under-five mortality due to HIV/AIDS, the 
impact of HIV/AIDS on neonatal survival and trends of under-five, infant and neonatal 
mortality indicators in Botswana, Malawi and South Africa. 
2.1 Estimation of under-five mortality by the IGME 
Estimates of under-five and infant mortality rates given by different organisations within 
the UN system, such as UNICEF, WHO, UNPD and the World Bank, differed prior to 
2004 because they were using different sources of data and methods of computation 
(UNICEF, WHO, UNPD et al. 2007). This created problems for appraising the 
achievement of MDG 4, and designing appropriate policies to ensure the achievement 
of this goal. As a result, the IGME, which consists of people from the UNICEF, WHO, 
UNPD, World Bank and a group of experts in the field (UNICEF, WHO, UNPD et al. 
2011b) was formed in 2004. The purpose of forming this group, as indicated  by 
UNICEF, WHO, UNPD et al. (2007), was to share data, to use standard methods, 
monitor progress towards the achievement of MDG 4, improve estimation methods 
and produce similar results and to allow comparison between countries. 
The estimates of under-five mortality for most developing countries are obtained 
from survey data only, but in some developing countries they are obtained from both 
survey and vital registration data (UNICEF, WHO, UNPD et al. 2010). The levels and 
trend of under-five mortality computed from different data sources may differ widely, 
which causes difficulty in determining the likely pattern and level of under-five mortality 
in a given country. Therefore, the IGME estimates the average pattern and level of 
under-five mortality by fitting a regression curve to the estimates of under-five mortality 
computed from survey and vital registration data collected from 1960 onwards at their 
reference time points, however; for countries affected by HIV/AIDS the curve is fitted 











spline or loess regression curve depending on the level of the prevalence of HIV/AIDS 
in the country (UNICEF, WHO, UNPD et al. 2007, 2010). 
According to the IGME, for countries with low levels of HIV/AIDS, that is an 
HIV prevalence rate of less than 5% at any point in time since 1980, a weighted linear 
spline regression1 is fitted to the natural logarithm of the under-five mortality and the 
time to which the estimate refers. A linear spline regression allows the rate of change of 
under-five mortality to change over the entire period of observation (UNICEF, WHO, 
UNPD et al. 2010). Thus, the slope of under-five mortality, which changes at each knot, 
is assumed to be linear between knots. According to the IGME (UNICEF, WHO, 
UNPD et al. 2007), a set of under-five mortality estimates obtained from survey data 
using direct or indirect methods or estimates obtained from five years of vital 
registration data are assumed to represent a particular slope of under-five mortality 
(UNICEF, WHO, UNPD et al. 2010). 
The weight assigned by the IGME to the estimates of under-five mortality 
depends on the source of the data, the accuracy of the estimates within that source of 
data (vital registration, full birth history or summary birth history data) and the 
estimation techniques used (direct or indirect) (UNICEF, WHO, UNPD et al. 2007). 
Moreover, the IGME assumes that the sum of the weights given to the under-five 
mortality rates computed from a full birth history data, summary birth history data and 
five years vital registration data is 5 and define a slope (UNICEF, WHO, UNPD et al. 
2010). For each estimate computed from civil registration data a weight of 1 is assigned 
because the estimate is coming from a large data set and there is no significant 
difference between the time of death and the time of registration of the death. The 
weight given to an estimate computed from survey data is based on the time gap 
between the occurrence of the event and the reporting of that event. Accordingly, the 
estimates of under-five mortality referring to events further apart in time are less reliable 
than those referring to events in the recent period. Hence, the weight given to estimates 
derived from full birth history data differ according to the length of time before the 
survey date to which the given estimate of mortality refers. Thus, estimates in the five 
years immediately before the survey are given a weight of 2, estimates referring between 
                                                
1
 The IGME (Hill, K., You, D., Inoue, M., Oestergaard, M.Z. et al. 2012, researchers working in the IGME) have changed the type 
of the regression model fitted to the under-five mortality rate of countries not affected by HIV/AIDS epidemic from spline to loess. 
One may question why this thesis could not take into account this change in the literature discussed above.  However, by the time 











5 to 9 and 10 to 14 years before the survey date are given a weight of 1.8 and 1.2 
respectively (UNICEF, WHO, UNPD et al. 2007). 
The weight given to estimates computed using the Brass children ever born and 
children surviving method depends on the age of women in the reproductive age group. 
The estimates corresponding to women in the 15-19 and 20-24 age groups are given a 
weight of zero and 0.2 respectively, due to sampling problems and the higher mortality 
of children of younger women. Under-five mortality rates computed from data on 
women in the age group 25-29, 30-34 and 35-39 are assigned a weight of 1.2. The 
quality of data on children ever born/children surviving is assumed to be poor for older 
women, thus the weight given for an estimate computed using data obtained from 
women in the age group 40 to 44 is 0.8 and it is 0.4 for an estimate computed using data 
from women in the age group 45 to 49 (UNICEF, WHO, UNPD et al. 2007, 2010). If a 
given survey contributes two types of estimates using direct and indirect methods, the 
weights given to them are reduced to half in order to avoid over representing a 
particular data set. The sum of the weights is important for limiting the number and 
position of knots. A knot is determined by working backwards in time, beginning from 
the most recent estimate of under-five mortality. Thus whenever the sum of the weights 
of successive under-five mortality becomes a multiple of five a knot is determined; the 
only exception to this rule is the first knot. The first knot is determined in such a way 
that the sum of the weights for the remaining observation is at least five (UNICEF, 
WHO, UNPD et al. 2010). 
The model that relates the natural logarithm of under-five mortality with the 








10 )()()5ln( ε      
where U5MR is the under-five mortality rate, date is the calendar year or the reference 
date of the under-five mortality rate, n is the number of knots, k1, k2,…,kn, are the 
position of the knots, +− )( ikdate  is equal to zero if date < ki, and +− )( ikdate  if date 
≥ ki, bis represent the rates of change in the value of under-five mortality, ε is the error 
term which is assumed to be normally distributed around the natural logarithm of 
under-five mortality with a mean of zero and a constant variance. 
The model fitted to the observed data is examined to decide if there are some 
inconsistent observations or outliers which are likely to affect the results. According to 











are reduced by a constant factor such as by multiplying the corresponding weights by 
0.5, 0.25 or 0 and the model is fitted again with the revised weights (UNICEF, WHO, 
UNPD et al. 2007). This model is used to find a smooth trend of under-five mortality 
over the entire period and to project/estimate the value of under-five mortality for a 
required date. 
For countries affected by HIV/AIDS (that is an HIV prevalence rate at any point 
in time since 1980 exceeding 5%, also HIV is firmly established in the general 
population and sexual networking in the general population is sufficient to sustain the 
epidemic) the under-five mortality rates are biased downwards because deaths of HIV-
positive children are likely to be underreported since mothers of these children are also 
likely to die due to HIV/AIDS and hence their deaths are not reflected in the estimate. 
Thus a technique has been developed by the Technical Advisory Group (a group 
consisting of scholars in the field of Demography and Biostatistics) of IGME for 
correcting the bias in the under-five mortality rates computed from full birth history 
(see section 2.9.2 for further detail about the method used for correcting the bias). Since 
the IGME has not developed a method for correcting the bias in the indirect under-five 
mortality rates due to HIV/AIDS, the indirect estimates in the period of HIV/AIDS 
epidemic are excluded from the modelling process (UNICEF, WHO, UNPD et al. 
2010). Moreover, the under-five mortality rates computed from full birth history data 
are also affected by birth transference (shifting births back in time). After correcting the 
bias due to HIV/AIDS and birth transference, the AIDS under-five mortality which is 
obtained by the UNAIDS is subtracted from the all-cause under-five mortality rate to 
get the corresponding non-AIDS mortality rate. A loess regression model is then fitted 
to the natural logarithm of the non-AIDS under-five mortality and the reference date. 
This model is then used to estimate/project the level as well as the pattern of the non-
AIDS under-five mortality rates. The corresponding AIDS under-five mortality 
obtained from UNAIDS estimate is added back to the estimated/projected non-AIDS 
under-five mortality rate to get the overall under-five mortality rate (UNICEF, WHO, 
UNPD et al. 2010). According to the IGME, a loess regression model is fitted because it 
captures the dynamic nature of under-five mortality rates in these countries (UNICEF, 
WHO, UNPD et al. 2010). The loess regression model used by the IGME is given as:  











where y is the natural logarithm of the non-AIDS under-five mortality, x is the time at 
which the rate applies, z is a variable which is 1 if the observed value is obtained from 
civil registration system and 0 otherwise and ε  is the error term. 
According to Silverwood and Cousens (2007), the loess regression equation is 
determined by using techniques of weighted least square regression. That is weights are 
allocated for all observed data, y using a weighting function in the following way. The 
weighting function is regulated by the value of  . Thus if the value of alpha is less than 
one the weighting function is calculated from the 100* % of the data. The weighting 
function is given as:  





      
where ψ is the minimum value of the absolute difference between x-xo (xo is the time 
point at which the estimate by the fitted model is required) and Ψ is the maximum value 
of the absolute difference between x-xo computed from 100* % of the data. But if the 
value of alpha is greater than one the weighting function involves all the data and it is 
given by the formula: 







Thus in order to fit a loess regression to the data for a given country, one starts 
with a minimum value of   so that at least 3 points are used in computing the weight 
for a given y value, and then the fit of the curve is checked. If it is not good, the weights 
are recalculated with   increased by 0.05 and the curve refitted and rechecked for 
goodness of fit. For alpha greater than one the value of alpha is increased by 0.1 at each 
step; but the maximum value of alpha should not be greater than two (Silverwood and 
Cousens 2007). 
The IGME assumes a linear pattern of under-five mortality between knots. 
However, Alkema and Ann (2011) argue that this may lead to incorrect estimates of the 
level and pattern of under-five mortality, especially when there exist large variations 
among observations between knots. In addition, they argue that a linear spline causes 
sudden changes in the rate of change of under-five mortality between the knots, which 
results in instability in the estimated under-five mortality rates. Thus the above problem 
affects not only the value of the under-five mortality but also the infant and neonatal 
mortality rates which are computed from the under-five mortality rate. In addition 











results using the method described. They also argue that, in Sub-Saharan Africa the 
estimates of under-five mortality appear to be exaggerated, which could be because of 
the assumptions made about the likely impact of HIV/AIDS on child mortality, the 
absence of data for recent periods, the removal of certain estimates assuming that they 
are aberrant and the assumptions made about incomplete data. Hence, a spline 
regression used by the IGME for countries in sub-Saharan Africa except those affected 
by the HIV/AIDS epidemic (loess regression is fitted in these countries) does not 
address the above problems. 
The IGME’s technique for adjusting the bias in the under-five mortality estimates 
due to HIV/AIDS in the epidemic period only applies to full birth history data. Thus 
the estimates computed from summary birth history data in the period are excluded in 
the estimation process (UNICEF, WHO, UNPD et al. 2010). The exclusion of under-
five mortality rates computed from summary birth history data in the modeling process 
is a loss of important information and probably the inclusion of these estimates in the 
modeling process would change the estimates released by the IGME. 
2.2 Estimation of infant mortality by the IGME 
The IGME produces a set of infant and under-five mortality estimates computed from 
survey data and/or civil registration data (UNICEF, WHO, UNPD et al. 2007). For 
countries with a reliable source of vital registration data a model is fitted to the 
relationship between the natural logarithm of the infant mortality rate and the reference 
date because vital statistics data provide a better estimate of the infant mortality rate 
than the under-five mortality rate (UNICEF, WHO, UNPD et al. 2007, 2010). However, 
for countries that rely on the full birth history data or summary birth history data, the 
infant death data may be poorer in quality than that used to estimate the under-five 
mortality rate. This is because the estimates of infant mortality rates computed from 
census data depend on the model life table used in the computation. Furthermore, in 
the case of full birth history data infant deaths are likely to be under-reported and may 
be wrongly reported as if they occurred in the age range between one and four years. 
However, all these problems are relatively less common for under-five death data than 
infant death data. Therefore in these countries the model is fitted to the under-five 
mortality rate rather than the infant mortality rate and the latter is determined from the 
under-five mortality rate estimated using the fitted model. The IGME uses different 
procedures for estimating the infant mortality rate for countries with high and low levels 











interpolated from the under-five mortality rate using the Coale and Demeny model life 
table or UN model life table. However, in countries with a high level of HIV/AIDS, the 
non-AIDS under-five mortality rate is determined by subtracting the AIDS under-five 
mortality, which is obtained from the UNAIDS estimate. Then the non-AIDS infant 
mortality rate is interpolated from the non-AIDS under-five mortality rate using the 
Coale and Demeny model life table or UN model life table. The all-cause infant 
mortality rate is determined by adding the corresponding UNAIDS estimate of AIDS 
infant mortality rate to the resulting estimate of the non-AIDS infant mortality rate (Hill 
and Amozou 2006; UNICEF, WHO, UNPD et al. 2007). 
2.3   Estimation of neonatal mortality by the IGME 
The IGME has recently developed a method for estimating neonatal mortality from 
under-five mortality (WHO 2010). This estimates are determined by relating the 
observed neonatal mortality rates and under-five mortality rates computed from survey 
data and vital statistics data (Oestergaard, Inoue, Yoshida et al. 2011; UNICEF, WHO, 
UNPD et al. 2011a). These rates are adjusted to maintain consistency with the IGME’s 
estimates of under-five mortality rates. In addition, the proportionate difference 
between the adjusted neonatal mortality rate and the under-five mortality rate computed 
from all mortality estimates is assumed to be the same. Two models have been 
developed by the IGME, depending on the source and quality of data available for 
measuring mortality rates (UNICEF, WHO, UNPD et al. 2010). 
The first method is applicable for countries having high quality vital statistics data 
(with no incompleteness for adult data and where the discrepancy between the under-
five mortality rates computed from vital statistics data and by the IGME is less than 
15%), having very few missing neonatal and under-five mortality rates (for example if 
data between 1990 and 2009 are used for developing the model, there must be 
observations at least for 17 years out of the 20 years and the number of successive years 
with no observation are less than three). This method computes the ratios between the 
adjusted neonatal mortality rates and the under-five mortality rates. Thus if the neonatal 
mortality rate is unknown for a particular year of interest, it is estimated as the average 
value of the ratios closest to the year of interest multiplied by the under-five mortality 
rate in the corresponding year or if we want to project for short periods from one to 
two years the ratio of the most recent observations multiplied by the under-five 
mortality rate in the year of interest is used (Oestergaard, Inoue, Yoshida et al. 2011; 











The second method is used for countries which do not have high quality civil 
registration data. It fits a multilevel regression model to the natural logarithm of 
observed neonatal mortality and under-five mortality (without removing the HIV trend 
in the under-five mortality)2 computed from the survey and vital registration data. This 
model was selected by the IGME as the best performing model among the available 
potential models after evaluating its prediction power by using the absolute and relative 
difference between the observed and predicted value of neonatal mortality rates. The 
inclusion of mortality estimates computed from data further back in time at each survey 
do not improve the prediction and estimation power of the model and also increases 
noise in the model, thus, it is fitted only to the recent data in a survey and only uses data 
from 1990 onwards (Oestergaard, Inoue, Yoshida et al. 2011; UNICEF, WHO, UNPD 
et al. 2010). 
The equation of this model is: 
[ ] [ ] iikijMRUMRUNMR εθδββα +++++=
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where ][ijδ  and ][ikθ are country level and region level random effects respectively for 
observation i, NMR and U5MR are the neonatal and under-five mortality rates 
respectively, and ɛi is the error or random term and it is assumed to be normally 
distributed with mean zero. 
2.4 Other approaches for estimating infant and neonatal mortality from the 
under-five mortality 
2.4.1 The Blacker and Brass model and estimation of infant mortality rate 
Blacker and Brass (2005) note that mortality declines at a faster rate during the early ages 
of life and then it levels off. Thus the pattern looks like a hyperbola. Blacker and Brass 
(2005) use this idea to model the life table survivorship curve at early ages of life with 
the following equation: 
   βα −+= )1()( xxl                                                                                                        
where x is the age in years or months;   is a constant and measures the level of 
mortality (determine the rate of change in mortality) and   is also a constant which 
measures the pattern of mortality. The value of alpha and beta need to be determined in 
order to get the value of the survival function at any age, either in months or years. If 
any two l(x) values are known say l(1) and l(5) we can get the value of alpha and beta.  
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 During examination of the dissertation the IGME released revised estimates of neonatal mortality (Hill, You, Inoue et al 2012) 











For illustration purposes Blacker and Brass (2005) used two data sets showing 
different patterns of mortality in the early ages of life. These are the 1992 Bangladesh 
data collected by the International Centre for Diarrhoeal Disease Research, which 
shows high mortality during infancy relative to mortality in the age range 1 to 5 and the 
other is the 1962-1968 data from Sine Saloum of Senegal, which shows a higher rate of 
mortality in the age band one to five as compared to infancy. They used the observed 
values of l(6) and l(60), where age is measure in months, from the Bangladesh data to 
find the value of alpha and beta. The estimates of l(x) computed from the fitted model 
are very close to the observed values, except in the first month. Therefore, the 
discrepancy between the value of neonatal mortality determined by subtracting the 
estimated value of l(1) from 1 and the observed neonatal mortality is relatively large. The 
model is also fitted to the data of Sine Saloum of Senegal using l(6) and l(60) and l(12) 
and l(60).  The estimated values of l(x) computed from the model fitted using l(6) and 
l(60) do not follow the observed pattern. However, the model fitted using the values of 
l(12) and l(60) produces results that follow the observed pattern as compared to the 
earlier model. Hence the model is not flexible enough to capture the different patterns 
of mortality and may not produce reasonable results for ages less than one year.   
2.4.2 The Keyfitz model and estimation of infant mortality rate 
Keyfitz (1966) suggests that the age pattern of morality at earlier ages doesn’t follow an 
exponential or polynomial curve. He tried a few curves, for example, assuming a linear 
curve between l0 and l1 and a parabolic pattern between l0, and l5. The curve which 
assumes a linear pattern of the survival curve during infancy produces a very high value 
of 1L0 and the curve that assumes a parabola does not produce a result close to the 
observed value. Keyfitz (1966) proposes the following curve for the age pattern of 
survival at early ages: 
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The values of a and b must be determined to compute the values of l(x) at the early ages 
of life. Thus, if any two values of l(x) say l(x1) and l(5) are known, a and b are estimated 
simultaneously. 
       He checked the performance of the model by comparing the person year (1LX) 
values produced by the model with observed values. He used the observed value of l(1) 
and l(5), where age is in years to determine the parameters of the model. The results 











The model may not produce reasonable probability estimates since the probability of 
dying and the person years lived are different measures which are computed differently.   
2.4.3 The Weibull distribution and estimation of infant mortality rate 
Carriere (1992) suggests that the age pattern of survival at the earlier ages can be 
modeled by a Weibull distribution as follows: 
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where m  is a parameter that measures the mode of the distribution and   is a parameter 
which measures the dispersion of the distribution. If two l(x) values are given the value 
of m and   are determined simultaneously from the above equation. This model is 
developed for modeling mortality at all ages by adding additional terms and not 
specifically for age pattern of survival at early ages like the Blacker and Brass and 
Keyfitz models, hence it is not used for assessing the IGME results.  
2.4.4 The Heligman and Polard model 
Heligman and Pollard (1980) propose that the age pattern of mortality at the early ages 
declines rapidly with an exponential pattern. Thus they suggest the following curve to 
model the age pattern of mortality at the early ages: 
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where qx and px are the probability of dying and surviving between age x and x+1 
respectively, A is a parameter that measures the level of mortality, B and C are also 
parameters that measure mortality change between age zero and one, and the rate of 
mortality decline, respectively. The model is a three parameters model and hence one 
cannot determine these parameters if only two l(x)s are given and it is include here for 
the sake of completeness and not used for assessing the IGME results.  
2.4.5 The IHME method of estimating mortality measures under five years of age 
2.4.5.1 The IHME method of estimating the under-five mortality rate   
The Institute of Health Metric Evaluation (IHME) developed a technique for 
estimating/projecting the pattern and level of under-five mortality rates by fitting a 
model that relates the observed under-five mortality rates computed from different data 
sources to the time to which the estimates refer. Rajaratnam, Marcus, Flaxman et al. 
(2010) argue that using a single model to estimate/project the level and pattern of 











best one. Moreover, this single model may not capture the change in the trend of under-
five mortality over time and hence misses some patterns like the change in the pattern 
of the under-five mortality due to the HIV/AIDS epidemic. Therefore, in order to 
resolve the above issues the IHME fitted a loess regression model, f(t) between the log 
of the under-five mortality rate and the time to which the estimates refer. Since there is 
uncertainty about f(t), the IHME define a Gaussian process distribution over X = f(t). 
The Gaussian process distribution assumes a normal probability distribution to any 
linear combination of f(t) which is denoted as:  
      f ~ GP(M, C), 
where M and C denote the mean and covariance function.   
The IHME include a term in the above model in order to take into account the 
level of incompleteness in the vital registration data. Thus the above model is modified 
as: 
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where  t,s is the logarithm of the under-five mortality at time t from a given data source, 
and s is the source of the data,  s=VRI =1 if the source of the data is incomplete vital and 
sample registration system and 0 otherwise,  VRI is a term added to take into account 
the bias in the under-five mortality rates if the vital registration data is incomplete in a 
given country (see the web appendix of Rajaratnam, Marcus, Flaxman et al. (2010) for 
further detail about  VRI ). 
The probability distribution of the above model is determined using the Bayesian 
approach to generate number of possible distributions. Hence Markov Chain Monte 
Carlo is used to sample 1,000 models after ignoring the first 3,000 models and the 
median value of the parameters and their 95% confidence interval are determined from 
the selected 1,000 models. 
The major limitation of the IHME method is the use of the under-five mortality 
rates computed from survey data in the modelling process without making correction 
for the bias introduced due to HIV/AIDS.   
2.4.5.2 The IHME method of estimating infant and neonatal mortality rate 
The IHME estimated the sex-specific early neonatal, late neonatal, postneonatal, infant 
and childhood mortality rates from the under-five mortality rate in a two-step modeling 
process (Lozano, Wang, Foreman et al. 2011). In the first step they estimated the sex-











mortality rates computed from vital registration data and full birth history data. Those 
results computed from incomplete vital registration data, results coming from countries 
having a total number of under-five deaths below 200 and an unreasonable sex ratio at 
birth being excluded since they are unreliable. They grouped those data that are assumed 
as reliable into 20 bins and fit the following model: 
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where 5q0 male and 5q0 female are the male and female under-five mortality rates, respectively, 
  is a constant,  5qo bin is the bin effect (an indicator that shows the group of the 
estimate),  region  is the region effect,  country is the country effect and ɛ is the random 
component. The bin effect ( 5q0 bin) may not capture the non-linear relationship between 
the sex ratio at birth and the level of the U5MR, hence a loess regression is fitted between 
the bin effect (determined from the above model by substituting the value of the ratio 
of male to female under-five mortality rate,   and the country and the region effect), 
and the observed under-five mortality rate for both sexes, 5q0, i.e.  
’
5q0 bin=f(5q0). Thus the 
above equation is modified as: 
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Using the concept of sex ratio, the combined under-five mortality rate is expressed as: 
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Thus the male and female under-five mortality rates are computed by solving the above 
two equations.  
In the second stage a regression curve is fitted between each sex specific early 
neonatal, late neonatal, post neonatal, infant mortality and childhood, and the under-five 
mortality rate. The model is given as: 
    εγγγβ ++++= countryregionbinqyageatdyingpr 05))(log( .                          
Then a loess regression is fitted between the logarithm of the probability of dying at age 
y estimated using the above equation and the observed sex specific under-five mortality 
rate. The combined mortality rates including infant mortality rates are determined by 
combining the sex specific mortality rates. The neonatal mortality rate (NMR) can be 
determined from the postneonatal and infant mortality rate computed using the IHME 
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2.5 Age pattern of mortality below five years of age 
The probability of death differs markedly by age during the early years of life especially 
between ages 0 and 5 years (Obungu, Kizito and Bicego 1994; Sullivan, Rutstein and 
Bicego 1994), with the probability being highest during the first year of life (Sullivan, 
Rutstein and Bicego 1994). For example the percentage contribution of infant mortality 
to under-five mortality in Nigeria and Sir Lanka is about 74% and 93% respectively 
(Chaudhury, Gunasekera and Gunasekera 2006; Ojikutu 2008). The mortality rate also 
differs significantly at further age break-downs such as in months. The hazard of 
mortality in the first  month of life after birth is higher than any one month age interval 
during the human life period (Lawn, Cousens and Zupan 2005). The neonatal mortality 
rate, therefore, contributes a considerable proportion, on average about 40% and 67%, 
to the world’s under-five mortality and  infant mortality rate, respectively (Hyder, Wali 
and McGuckin 2003; Lawn, Cousens and Zupan 2005). Lawn, Cousens and Zupan 
(2005) indicate that, the percentage contribution of neonatal mortality to under-five 
mortality differs from region to region and from country to country. Hall (2005) 
suggests that in regions such as Western Europe where the under-five mortality rate is 
very low, the percentage contribution of neonatal mortality to under-five mortality is 
estimated to be about 75%, whereas in sub-Saharan Africa where the under-five 
mortality is high the percentage contribution of neonatal mortality to under-five 
mortality is less than 25%. According to a report by WHO (2006), the share of neonatal 
mortality to under-five mortality is estimated to be 42% in Latin America. Another 
study conducted by Garde and Sabina (2010) using DHS data in South Asian countries 
having low level of child mortality, such as Bangladesh during  2007, Nepal in 2006 and 
Philippines during 2008, the contribution of neonatal mortality to under-five mortality is 
48%, 53% and 45%  respectively.     
Obungu, Kizito and Bicego (1994) suggest that, as the rate of mortality between 
ages 0 and 5 years declines the proportion of the under-five mortality rate concentrated 
at the earlier age rises, especially during infancy and the neonatal period. Thus the ratio 
of neonatal mortality rate to under-five mortality rate and infant mortality rate to under-
five mortality rate increases as the under-five mortality rate declines, also the ratio of the 
neonatal mortality rate to the infant mortality rate rises as the infant mortality rate 











2011). However, there is evidence that this increase in the ratio of the neonatal mortality 
rate to the under-five mortality rate following the reduction in the under-five mortality 
rate may be reversed when mortality rates are very low (Andreev 2011)    
Figure 2.1 shows the plot of the ratio of infant mortality (1q0) to the under-five 
mortality (5q0) computed from the Coale and Demeny model life tables and the UN-
model life tables for developing countries, showing that, as the under-five mortality 
declines, the ratio of infant mortality to under-five mortality increases. 
Figure 2.1 Plot of the ratio IMR to U5MR against U5MR- from the Coale and Demeny 

















Nrth	  Msl South	  Mdl Est	  Mdl
West	  Mdl Latn	  Amer Chilean
South	  Asian Far	  estrn Gnrl	  ptrn  
2.5.1 The common model life tables 
2.5.1.1 The Coale and Demeny model life table 
The Coale and Demeny model life tables are constructed using registered deaths by age 
obtained from populations living in developed countries (Pollard, Yusuf and Pollard 
1991; Preston, Heuveline and Guillot 2001; UN 1983). The major limitation of the 
Coale and Demeny model life tables is that it is heavily weighted to the mortality 
experience of the European population and hence may not represent the mortality of 
populations in the developing countries. According to the pattern revealed, these life 
tables are grouped into four categories, such as:  “West”, “East”, “North” and “South”. 
The West pattern exhibits a mortality shape which is similar to the average mortality 
pattern revealed by all the available life tables; however, the remaining patterns (East, 
North and South) are significantly different from this pattern (Pollard, Yusuf and 
Pollard 1991). These model life table systems are discussed below. 
The East pattern is characterised by high infant death rates as compared to the west 











The North pattern shows a low level of mortality below age one coupled with a high level 
of mortality between ages one and five years (Preston, Heuveline and Guillot 2001; UN 
1983).             
The South pattern has high ratio of infant mortality to childhood mortality as compared 
to the West pattern when the under-five mortality is less than 125 per 1000 otherwise 
the pattern has low ratio of infant mortality to under-five as compared to the west 
pattern. 
2.5.1.2 The UN model life table for developing countries 
The UN model life tables are constructed using a collection of 72 life tables for each sex 
obtained from developing countries (UN 1983). The mortality patterns revealed by 
these life tables are categorised into the Latin American, the Chilean, the South Asian, 
and the Far Eastern patterns, depending on the geographical region predominant within 
each pattern group and the General pattern (the average pattern of all life tables) (UN 
1982). The characteristics of these patterns are: 
The Latin American pattern is characterised by a higher concentration of mortality during 
infancy than between ages one and five years as compared to the case in the General 
pattern. 
The Chilean pattern shows very high mortality during infancy relative to the childhood 
period.  
The Far Eastern pattern has some similarities to the Chilean pattern but has very low 
infant mortality as compared to the Chilean pattern.  
The South Asian pattern has virtually the same ratio of infant mortality to childhood 
mortality as compared to the General pattern.   
Although the UN model life tables for developing countries are constructed using 
data obtained from developing countries, the representativeness of the UN model life 
tables to the mortality of the population of Africa is questionable since the data included 
only one African country (UN 1983).    
2.6 Sources of data for estimating neonatal, infant and under-five mortality 
2.6.1 Vital registration 
The registration of births and deaths on a continuous basis provides the most important 
and reliable information on the measurement of neonatal, infant and under-five 
mortality rates (Hill 1991). The vital statistics data are recorded shortly after the 











thus provides timely information about the level of neonatal, infant and under-five 
mortality. However, in most developing countries, especially those in sub-Saharan that 
collect vital statistics data the quality of the data is poor (Ahmad, Lopez and Inoue 2000; 
UNICEF, WHO, UNPD et al. 2007). The births and deaths from poor and rural 
households are less likely to be reported and children from these households are more 
likely to die. Even in those countries which have a higher quality vital statistics data late 
registration of births and deaths is a problem. Mostly, those births and deaths not 
reported shortly after their occurrence are less likely to be reported later. Due to the 
above reasons, therefore, the estimates using vital registration may underestimate the 
true rate of mortality. 
2.6.2 Sample registration  
Sample registration systems record births and deaths prospectively from a representative 
of household. The system collects the required data on a regular basis (every six months 
or on a yearly basis) by following the same households (Hill 1991; Hill, Lopez, Shibuya 
et al. 2007). The data from this source are used to produce accurate estimates of 
mortality at ages below five years, especially the under-five mortality if the data 
collection process is carefully monitored (Hill 1991; UNICEF, WHO, UNPD et al. 
2007). Sometimes the estimates from a sample registration system may not adequately 
represent the national figure since a very small portion of the population is covered by 
the system. For example in India, only 1% of the population are covered by the survey 
(Hill, Lopez, Shibuya et al. 2007). The system is implemented in only a few countries 
since it is very costly. 
2.6.3 Census 
Population censuses are another source of data for the measurement of infant and 
under-five mortality, but not neonatal mortality. Population censuses collect summary 
birth history data, survival of most recent births or births in the last 12 months and 
information about the previous birth. Most of the time it collects the required 
information from women in the age group 15 to 49 years about the number of children 
they have had and the number of children who are still alive (UNICEF, WHO, UNPD 
et al. 2007). Under-five and infant mortality rates are estimated from the summary birth 
history data (see section 2.7.1 for further detail).  
In addition, a few censuses collect information about the survival of most recent 
birth or birth in the last 12 months. The proportion dead computed using data about 











of one year prior to the survey date. The proportion of dead computed using data about 
the survival of most recent births approximates the probability of dying at age two if the 
average birth interval is 2.5 years. The proportion underestimates the probability of 
dying at age two if the average birth interval is less than 2.5 years and overestimates if 
the average birth interval longer than 2.5 years (Hill and Aguirre 1990). However, the 
mortality estimates computed using data of the survival of births in the last 12 months 
or the most recent birth are under-estimated, probably due to under-reporting of births 
and deaths and/or due to few births occurring within the past 12 months (Hill 1991). 
Blacker and Brass (2005) developed a method for estimating the infant mortality 
rate, q(1) from the proportion dead among children born in the last 24 months, D form 
survey data collected about the survival of previous birth. The method assumes 
that βα −+= )1()( xxl , where x is age in the early years of life after birth (see section 2.4.1 
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An adjustment factor q(1)/D, which is used for converting the proportion dead among 
births in the last 24 months into q(1) can be determined if alpha and beta are known. 
They determined the correction factor using simulation approach, and the correction 
factor ranged from 1.04 to 1.097 with an average value of 1.092. Mostly the proportion, 
D is multiplied by 1.092 since the estimate is robust to the selection of correction 
factors Blacker and Brass (2005) . 
2.6.4 Household surveys 
Censuses are generally conducted once every 10 years and the vital statistics registration 
system is incomplete or non-existent in most developing countries. Therefore it may be 
difficult to get estimates of neonatal, infant and under-five mortality rates over inter-
censual periods. A possible option is to include information on child mortality in 
surveys (Hill 1991). Demographic and health surveys (DHSs) and the multiple indicator 
cluster surveys (MICSs) are the most common ones used for the measurement of 
mortality  between ages 0 and 5 years (Mahy 2003). Demographic and health surveys 
collect full birth history data from women in the child-bearing age group. Thus DHSs 
ask women about the month and year of birth for each live-birth. If the child has died, 
the DHS collects the age at death in days, if the death occurred within the first 28 days 
after birth, in months, if the death occurred between one and 23 months, and in years if 
death occurred between ages two and five (Hill and Chio 2005). This information is 











Multiple indicator cluster surveys were initiated by UNICEF in countries which 
have conducted very few surveys or have not conducted a recent DHS, in order to help 
these countries appraise the progress towards the achievement of millennium 
development goals (Mahy 2003; UNICEF, WHO, UNPD et al. 2007). This survey 
collects summary birth history data from women in the reproductive age group, which is 
what censuses do.  
The most common problem with DHS data is heaping of age at death to whole 
numbers. Thus deaths occurring at days close to one month, 12 or 18 months may be 
reported as if they occurred on one month, 12 and 18 months after birth respectively. 
Moreover, since the survey asks women about the occurrence of events that occurred in 
the distant past, women may not be able to remember all of the events (births and 
deaths) and dates of occurrence of these events. The data obtained from surveys are 
affected by the selection method, death of the mother and migration. The data are also 
severely affected in countries affected by HIV/AIDS (Hill 1991).   
2.7 Methods of estimating mortality under the age of five  
2.7.1 Indirect method of estimating infant and child mortality 
Brass developed a method that converts the proportion of children dead among 
children ever born to women in the reproductive age group into probabilities of dying 
before reaching specific ages (Brass, Coale, Demeny et al. 1968; Mahy 2003; UN 1983). 
Thus if Di represents the proportion of children dead as reported by women in age 
group i (i = 1 if the age group is 15 - 19, 2 if the group 20 - 24 and so on) then the 
probability of dying before age x is given: 
      ))(()( iix kDq =  
where ki is the multiplier or factor for converting the proportion dead of children born 
to women in the ith age group into the probability of dying. Brass also determined that 
the most accurate probability measures computed using summary birth history data 
obtained from women in the age groups 15 - 19, 20 - 24,…,45 - 49 are the probability of 
dying before age 1, 2, 3, 5, 10,15, 20, respectively (Brass, Coale, Demeny et al. 1968). 
Brass pointed out that the association between Di and the probability of dying is 
determined by the age distribution of fertility. Thus ki is a function of the age pattern of 
fertility and mortality, and it is estimated by:  



















where k(i) is a multiplier, a(i), b(i) and c(i) are coefficients specific to each of the Coale 
and Demeny model life tables patterns and p1, p2, and p3 are average parties of women in 
the age group 15-19, 20-24 and 25-29, respectively. 
The probabilities of death computed from summary birth history data using the 
Brass method refer to periods in the past. Thus if mortality changes over time at a 
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where t(i) is the time to which the estimate refers, a(i), b(i) and c(i) are coefficients 
calculated for each of the Coale and Demeny model life table patterns, determined using 
analysis of simulated regression models (Hill 1991; UN 1983). 
 The probability of dying estimated using the Brass method is based on a number 
of assumptions, the most important being that the survival of a child is not affected by 
the death and age of the mother, birth order and other factors and is only affected by 
the age of a child. However, these assumptions may not be always true; for example, 
children of women in the age group 15-19 have a higher risk of dying than their 
counterparts (Hill 1991; Mahy 2003; UN 1983) and hence the child mortality rates for 
recent periods may be inflated. 
The other assumption made in this method is that fertility and mortality rates are 
assumed to be constant in the recent past. However, these rates are declining in most 
countries, although mortality has reversed due to HIV/AIDS in countries affected by 
the epidemic. Thus an assumption of constant fertility biases the mortality estimates 
upward. The assumption of constant mortality in the original Brass method is relaxed by 
Coale and Trussell (1974) and Feeney (1980). The other assumptions made by the 
method are affected by HIV/AIDS (see section 2.8 for details about the impact of 
HIV/AIDS on the assumptions).  
Common mortality measures, such as infant and under-five mortality rates, are 
computed from q(x) values determined by using the Brass method in order to see the 
trend of under-five or infant mortality (UN 1990). Brass related linearly the logit 
transformation of the curve of probability of dying of two life tables having the same 
pattern (UN 1983; Zaba 1979), i.e.  
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qit , q(x) and q
s
(x)  are the probability of dying by age x 
produced using the Brass method and obtained from a standard model life table, 
respectively,   and   are parameters which measure the level and pattern of mortality 
respectively. If the pattern of the observed q(x)s is the same as the standard model life 
table then   = 1. Therefore, from the above equation   is given as 
          ))(log)(log )()( x
s
x qitqit −=α  . 
Thus once the value of   implied by the value of each q(x) is determined the common 
measures are computed using the following equation: 
        1)(0 )))(log(2exp(1(1
−++−= xsx qitq α . 
2.7.2 The direct method of estimating mortalities under the age of five years 
The direct method of estimating mortality uses information of the date of a child’s birth,  
survival status of a child and age at death (in days, months or years) if the child died, 
collected from women in the reproductive age group (Rutstein and Rojas 2006). The 
mortality rates are determined from the data using the following approaches. The synthetic 
cohort approach divides the first five years after birth into intervals of below 1 month, 1-2, 
3-5, 6-11, 12-23, 24-35, 35-47, 48-59 months and computes the probability of dying in 
each interval by dividing the number of deaths in the interval by the number of 
surviving children at the beginning of the interval in a specified time period. These 
probabilities are then combined to get common measures of the probability of dying. 
For example, infant mortality is determined by subtracting from one the product of the 
complement of the probability of dying (i.e. probability of surviving) in the intervals 
below one month, 1-2, 3-5 and 6-11 (Rutstein and Rojas 2006). The vital statistics approach 
uses information of the number of births and infant deaths in the period (year) of 
interest in order to determine the infant mortality rate. Thus this rate is determined by 
dividing the number of infant deaths by the number of births in the period of interest. 
The under-five mortality rate is determined using the following equation: 













where 1mx is the mortality rate between ages x and x+1 and x = 1, 2, 3 and 4. The 
mortality rate is determined by dividing the number of deaths between ages x and x+1 
by the mid-year population aged x in the corresponding period. However, this method 
is limited to countries that have a complete vital statistics registration system (UN 1992). 











between two periods and the size of the cohort at the beginning of the period. Thus the 
cohort neonatal mortality rate is determined by dividing the number of deaths of 
children under age one month of a specified cohort by the number of births in that 
cohort. Similarly, the cohort infant mortality and cohort under-five mortality rate is 
determined by dividing the number of deaths below 1 year and 5 years by dividing the 
number of births in that cohort (Rutstein and Rojas 2006). 
2.8 Impact of HIV/AIDS on the estimation of infant and child mortality 
Most developing countries, especially those in sub-Saharan Africa, depend on census or 
survey data obtained from women of reproductive ages, for the estimation of infant and 
under-five mortality (Hill 1991; UNICEF, WHO, UNPD et al. 2007). Children of 
mothers infected with HIV have a higher chance of dying due to vertical transmission 
of HIV to the child or due to the indirect impact of HIV (Hallett, Gregson, Kurwa et al. 
2010; Marston, Zaba, Salomon et al. 2005; Nakiyingi, Bracher, Whitworth et al. 2003; 
UNICEF, WHO, UNPD et al. 2007). In countries affected by HIV/AIDS deaths of 
these children are under-reported in surveys or censuses due to the death of HIV-
positive mothers (Zaba, Marston and Floyd 2003). Thus the estimates of infant and 
under-five mortality rates computed from survey and census data using the direct and 
indirect method tend to underestimate the true rates.  
The impact of HIV/AIDS is higher on the indirect estimates than the direct 
estimates. This is because many of the assumptions of the indirect method are violated 
in contrast to only one for the direct method, as discussed below.  
The indirect estimation method of child mortality assumes that there is no 
association between child survival and age of mothers. However, the prevalence of 
HIV/AIDS varies with the age of a woman. Thus children born to women in the high 
HIV/AIDS infected age group are more likely to be infected with HIV and hence have 
a higher chance of dying. Therefore the survival status of children is dependent on the 
age of the mothers (Mahy 2003). According to a study by Stover, Johnson, Hallett et al. 
(2010) the incidence of HIV is high among women aged between 20 and 25 years. 
Assuming that the average survival of infected women is 10-15 years and give birth with 
in four years since infection the indirect estimate computed using data obtained from 
women aged 30-34 are under-estimated (Stover, Johnson, Hallett et al. 2010; UNICEF, 
WHO, UNPD et al. 2010).    
The Coale and Demeny model life tables are used for converting the proportion 











Brass method are converted into common measures, such as infant (1q0) and under-five 
(5q0) mortality rates using the Coale and Demeny model life tables. Moreover, the 
coefficients used for estimating the time to which the infant and under-five mortality 
rates refer are determined from the Coale and Demeny model life table. However, these 
model life tables are constructed based on mortality data from HIV free populations, 
and do not show the mortality pattern of populations affected by HIV/AIDS. The 
mortality estimates using these model life tables, therefore, are biased downwards (Mahy 
2003), and the time location of the under-five and infant mortality estimates for 
populations with HIV/AIDS may be incorrect. However, studies by Chitiyo (2011) and 
Mutemaringa (2011) suggest that the biases in the mortality measures as well as the time 
to which the estimates refer as a result of using the Coale and Demeny model life tables 
are insignificant.  
The direct and indirect estimation methods of child mortality use full birth history 
data and summary birth history data respectively, collected from women in the 
childbearing age group. The direct and the indirect methods of child mortality assume 
that the survival status of children is independent of the death of the mother. However, 
in countries affected by HIV/AIDS this assumption is violated because of the 
significant association between the survival status of a child and death of a mother 
(Adetunji 2000; Nakiyingi, Bracher, Whitworth et al. 2003) and surveys cannot collect 
information about the survival status of children from HIV positive mothers due to the 
absence of a mother due to her  HIV/AIDS death. Thus the estimates of infant and 
under-five mortality may be biased downward. However, these mortality estimates 
computed from full birth history data that occurred in the last five years are affected to a 
lesser extent compared to those data covering the earlier period because HIV positive 
women who give birth in the last 5 years are less likely to have died (Mahy 2003). 
2.9 Methods of correcting the bias due to HIV/AIDS on child and infant 
mortality estimation 
2.9.1 The Ward and Zaba correction method 
Ward and Zaba (2008) estimated the bias due to HIV/AIDS in the estimates of child 
mortality computed using the Brass CEB/CS method by simulating a stable population 
with different stable levels of HIV prevalence among women aged 15-49 years. A 
cohort of HIV negative women aged 15-49 years which reduces in size due to HIV 
infection and non-AIDS mortality is projected with time. For each simulation of 











estimated also the child mortality rate, ezq )( using the indirect method based on data 
that would have been reported by women if a cross-sectional survey was conducted. 
The difference between these two estimates approximates the error, n(z), introduced by 
HIV/AIDS in the indirect techniques of child mortality estimation. 
        Ward and Zaba fitted a regression equation between the prevalence of HIV among 
women in the childbearing age group and the n(z) values to estimate correction factors 
in the estimates of child mortality determined from birth history data. The regression 
equation is given as follows: 
                15)()( 2 cPREVPREVbaPREVzn ++=  
where a, b and c are regression coefficients for each five years reproductive age group 
and PREV and PREV15 are the prevalence of HIV among women in the age group 15-
49 and 15-19 respectively. Then the corrected estimate of child mortality is given as:  
            )()()( znzqzq et += . 
This method assumes that the population for which the estimates are required is 
stable and the prevalence of HIV is constant in the population. These assumptions are 
not true in practice. In addition, the method also assumes that the vertical transmission 
of HIV and mean survival time of adults is constant over time. These assumptions also 
do not hold true because the vertical transmission of HIV is reduced due to PMTCT 
programmes and the introduction of ART drugs (Dube, Boily, Mugurungi et al. 2008; 
Mahy 2003; Palombi, Marazzi, Voetberg et al. 2007; Stover, Fidzani, Molomo et al. 2008). 
2.9.2 The IGME (Hill and Walker) correction method 
The IGME has developed a method for correcting the bias introduced by HIV in full 
birth history data. The size of the bias depends on the extent to which child deaths are 
under-reported in surveys due to deaths of women because of HIV. 
The latest information about the prevalence of HIV/AIDS among pregnant 
women in the age group 15-49 years and the annual number of births obtained from 
UNAIDS for the population under study are used by the IGME to get the true births 
and under-five deaths for each year. These births are divided into three categories: HIV-
negative births from HIV-negative mothers; HIV-positive births from HIV-positive 
mothers and HIV-negative births from HIV-positive mothers. The model assumes that 











when the impact of PMTCT is ignored)3. For each annual number of births, deaths of 
children below five years are calculated for each category of births (HIV+ and HIV- 
births). The mortality experience of HIV-negative births is assumed to be the same 
regardless of the HIV status of the mother. Thus the under-five mortality rate of HIV-
negative births is determined using the “West” family of the Coale and Demeny model 
life tables. The mortality schedule for HIV-positive births is determined from cohort 
studies with an under-five mortality rate of 0.625. Moreover, it is also assumed that the 
impact of ARV is negligible before the year 2007.  
The IGME also determined the number of births and under-five deaths that 
would be reported by women in populations affected by HIV if a survey was conducted. 
In doing so, the IGME assumes that all HIV-negative women survive to the date of the 
survey, and hence births and deaths of all the children of these women are reported. In 
addition, the IGME assumes that an HIV-positive woman gives birth on average four 
years after infection. A survival curve with median survival time of 9.5 years since 
infection, obtained from cohort studies is used to create a mortality schedule of women 
after four years since infection. This curve helps to find the probability of survival of 
women from a given year to the survey date, which helps to find the number of births 
and under-five deaths reported by HIV-positive woman at the time of the surveys.  
The estimated bias due to HIV in full birth history data is determined as the ratio 
of the reported number of deaths of children divided by the reported number of 
children below five years of age to the true number of deaths of children divided by the 
true number of children below five years of age for each estimate corresponding to the 
periods 0-4, 5-9 and 10-14 years prior to the survey date. The under-five mortality rates 
computed from full birth history data can then be divided by this ratio in order to get 
the correct estimates of under-five mortality rates. 
The reasonableness of some of the assumptions made in this method such as: 
same survival status of HIV-negative births irrespective of the HIV status of the 
mother, births infected with HIV before and during delivery and through breastfeeding 
have same survival status, a median survival time of 9.5 years since infection, 35% of the 
births of HIV-positive mothers are HIV-positive and ART does not have an impact on 
the survival of children before 2007 are suspect and the impact of these assumptions on 
the resulting estimates are discussed in the result section (see section 4.1.3 for further 
                                                
3
 Walker, Hill and Zhao (2012), revised the IGME method that corrects the bias in child mortality computed form full birth history 
data by taking into account the impact of PMTCT on the reduction of the chance of HIV transmission from mother to child. 











detail) since this study aims to assess the IGME results also by assessing the impact of 
these assumptions on the estimates. 
2.9.3   The Hallet, Gregson, Kurwa e t  a l  correction method 
Hallett, Gregson, Kurwa et al. (2010) use annual female birth cohorts in rural Zimbabwe 
between 1920 and 2005 obtained from the United Nations Population Division in order 
to develop a stochastic simulation model. The model simulates the mortality and fertility 
patterns at individual level for each female birth cohort. In addition, the method 
produces information about the survival of the children of birth cohorts of women 
between 1920 and 2005. 
In order to get the non-AIDS mortality data, exponential models are fitted to the 
non-AIDS mortality pattern of the birth cohort for ages below 1 year and between 1 
and 4 years separately, using observed mortality rates before the period of HIV/AIDS. 
For ages 5 years and above, the non-AIDS expectation of life is determined using the 
non-AIDS mortality data obtained from the Manicaland, Zimbabwe HIV/STD 
prevention study.  
The non-HIV age-specific fertility rates for the rural birth cohorts are determined 
based on the observed rates before the start of HIV/AIDS epidemic. The HIV/AIDS 
age specific fertility rates and the rate of new HIV infection by age for the rural birth 
cohorts are determined using the bserved rates from the Manicaland HIV/STD 
prevention study. A Weibull survival curve fitted to data from cohort studies in a 
number of African countries is used to determine the survival status of HIV positive 
women.     
The model assumes that the woman starts taking ART when her CD4 count is 
less than 200 per microlitre of peripheral blood and the median time to death after the 
initiation of ARV is assumed to be 10 years. Moreover, ART is assumed to reduce the 
risk of HIV transmission to the child by 50%. The model also takes into account the 
dependence of the rate of HIV transmission from mother to child on the stage of the 
disease. The other assumption made by the model is that the survival time of an HIV-
positive child is calculated as the minimum of the life expectancies in the absence of 
AIDS. 
The model generates three types of data sets similar to those collected by DHS 
surveys. Accordingly, three types of infant and under-five mortality rates are computed 
from the data generated by the model over the period of observation. The first is the 











computed using the same method used in determining the infant and under-five 
mortality in DHS surveys. The second series is the “DHS continuous”, when the 
estimates are computed on a continuous basis, assuming that the data are obtained from 
a very large number of closely-spaced surveys and no censoring of child survival times. 
The third one is the “corrected” series, determined in the same way as the DHS 
continuous but in this case simulated child mortality data of women who died due to 
AIDS are included in the computation. The bias introduced due to HIV in the estimates 
of infant and under-five mortality is estimated by the difference between the corrected 
series and the DHS continuous series.  
This model also does not allow for the existence of variation between the survival 
of HIV-negative children born from HIV-positive and HIV-negative mothers (see 
section 4.1.3 for details about the impact of the failure to include this fact on the results 
estimates).  
2.10 The impact of HIV/AIDS on neonatal survival 
This section discusses the impact of HIV/AIDS on the survival of children of HIV-
positive mothers in the neonatal period. Brocklehurst and French (1998) used meta-
analysis and a systematic review of literature related to the impact of HIV/AIDS on 
neonatal mortality conducted between 1983 and 1996. In order to reduce 
methodological biases they included only research based on prospective cohort studies 
with sufficient data to compute confidence interval for the odds ratio. They found 31 
studies which satisfy the above requirements. According to their study, adverse 
pregnancy outcome is significantly correlated with the HIV-status of women and hence 
there is an excess risk of perinatal and infant mortality of children from HIV-positive 
mothers. However, although the odds ratio of neonatal mortality of children born to 
HIV-positive mothers was 1.1, it was insignificant at the 5% level of significance. They 
thus suggested that the correlation between HIV status and adverse pregnancy outcome 
could be because of confounding factors.  
A retrospective study conducted among 896 pregnant women (8.2% of whom 
were HIV-positive) admitted to St. Albert’s Mission Hospital, Zimbabwe suggests that 
perinatal mortality and infant mortality in the neonatal period was high. The situation is 
exacerbated for the women co-infected with HIV/AIDS and Malaria (Ticconi, 
Mapfumo, Dorrucci et al. 2003). Another prospective study conducted by Villamor, 
Msamanga, Aboud et al. (2005) in Tanzania on 275 HIV positive women indicates that 











co-infected with malaria than children of their counterparts. This is because HIV/AIDS 
increases the transmission rate of the malaria parasite to the child during pregnancy. A 
follow-up study conducted in Lusaka, Zambia on 1,229 HIV-positive pregnant women 
indicates that viral load is associated with maternal low body mass index, prematurity 
and low birth weight which are strong risk factors for neonatal mortality. However, the 
study concludes that deaths of infants due to HIV in the neonatal period is significantly 
small (Kim, Mwiya, Kankasa et al. 2011).   
A follow-up study conducted in Malawi on 2,608 women, 5.8% of whom were 
HIV positive, suggests there is no significant risk of neonatal mortality among children 
of HIV-positive mothers as compared to children of their counterparts (Bloland, 
Wirima, Steketee et al. 1995). A retrospective study conducted at Mowbray Maternity 
Hospital (MMH), South Africa on 18,870 births, 17.2% of them were to HIV-positive 
mothers, concludes that the odds of the early neonatal death rate among births from 
HIV-positive mothers is not significantly different from births from HIV-negative 
mothers. The possible explanation for this may be due to the high quality of neonatal 
care at MMH (Kennedy and Fawcus 2012). A prospective study conducted on 2,850 
women (50.8% of whom were HIV-positive) attending antenatal clinics in Kwazulu-
Natal, South Africa reveals that children of HIV-positive mothers do not show a 
significant risk of death as compared to children from HIV-negative mothers in the first 
six weeks of life (Rollins, Coovadia, Bland et al. 2007). A further study conducted in 
South Africa, which analysed registered infant deaths between 1997 and 2002 with age 
in month, found a significant rise in mortality between ages two and three months after 
birth, which could be attributed to HIV/AIDS,  suggesting that  absence of significant 
increase in mortality in the neonatal period could be because of the protective effect of 
acquired maternal immunity (Bourne, Thompson, Brody et al. 2009). 














3 METHOD OF ANALYSIS 
This chapter discusses the methods used for assessing the IGME methods and results. 
Sections 3.1 and 3.3 discuss the method of empirical and logical assessment of the 
under-five, infant and neonatal mortality rates. Section 3.2 presents the method used for 
assessing the IGME infant and neonatal mortality rates for consistency with the age 
pattern of mortality below five years of age. 
3.1 Methods of assessing the under-five mortality and infant mortality rates  
This study assesses the infant and neonatal mortality rates produced by the IGME for 
countries such as Botswana, South Africa and Malawi (Malawi was chosen because it is a 
country having high background mortality, high HIV prevalence and thought to be on 
track to meet millennium development goal 4, unlike the above countries according to 
the IGME results). These rates are computed from the under-five mortality rates 
estimated by the IGME and hence if errors exist in the under-five mortality rates they 
will affect the infant and neonatal mortality rates. It is necessary, therefore, to assess the 
reasonableness of the under-five mortality rates computed by the IGME in these 
countries.  
3.1.1 Empirical assessment of under-five and infant mortality rates 
In this study the under-five mortality and infant mortality rates determined by the 
IGME are compared with the estimates made by other organisations and institutions. 
The under-five mortality and infant mortality estimates of Botswana, Malawi and South 
Africa determined by the IGME are compared with the estimates from the United 
States Census Bureau (USCB), Spectrum 4.46b7, IHME and other published estimates. 
The estimates of under-five mortality and infant mortality rates made by the IHME for 
South Africa corresponding to periods of high mortality of children due to HIV/AIDS, 
aren’t compared to those of IGME since the IHME apparently used the vital statistics 
data of South Africa without adjusting for incompleteness and hence the results are 
misleading (Kerber, Tuaone-Nkhasi, Dorrington et al. 2012). In addition, the IGME 
under-five mortality and infant mortality estimates of Botswana and South Africa are 
compared to the estimates obtained from the ASSA2003 (Actuarial Society South Africa 
2003 model) of Botswana (the latest ASSA model available for Botswana)  and 
ASSA2008 of South Africa respectively. The ASSA2008 model is not used for 











the South African data as an input. The IGME estimates of under-five mortality and 
infant mortality are not compared with the United Nations Population Division, UNPD 
estimates since they are not independent of estimates of the IGME group.    
The comparison of the IGME under-five mortality and infant mortality estimates 
with the estimates by other institutions and researchers is made by comparing the 
magnitude of the under-five mortality and infant mortality rates of the IGME with 
those of the estimates made by others.   
3.1.2 Logical assessment of under-five mortality  
The IGME has also made assumptions in correcting the bias in the under-five mortality 
rate due to HIV/AIDS in full birth history data. This study therefore assesses the 
reasonableness and the impact of these assumptions on the IGME under-five mortality 
estimates by reviewing relevant literature. In addition, the IGME ignored the estimates 
of under-five mortality rates computed from summary birth history data using the 
indirect technique in the modelling process, because the IGME has not developed a 
technique for correcting the bias due to HIV/AIDS in these estimates. This study thus 
assesses the impact of ignoring these estimates on the IGME estimate of under-five 
mortality. The assessment is made by comparing the direct and indirect estimates of 
under-five mortality rates computed from DHS and MICS data corrected for the impact 
of HIV/AIDS. If the indirect estimate is larger than the direct estimate, then the IGME 
model fitted, excluding the indirect estimate, produce relatively lower estimates of 
under-five mortality rate and vice-versa. The direct estimates of under-five mortality 
rates corrected for the impact of HIV/AIDS are obtained from the IGME database and 
the indirect estimates are corrected for the impact of HIV/AIDS using the Ward and 
Zaba correction method by taking the prevalence of HIV/AIDS at a time which the 
estimates refer (Darikwa 2009). 
3.1.3 Logical assessment of infant mortality 
The IGME interpolates the non-AIDS under-five mortality rates of Botswana, Malawi 
and South Africa using the “West”, “North” and “West” model life tables, respectively 
(Spectrum uses “West”, “South” and “UN East Asia” for Botswana, Malawi and South 
Africa respectively), to produce a life table with the under-five mortality rate that 
corresponds to the estimated non-AIDS under-five mortality rate, the IMR from this 
life table is used to get the non-AIDS curve of infant mortality. The infant deaths due to 
HIV/AIDS determined by UNAIDS are added to the resulting non-AIDS infant 











of the UNAIDS estimate of the AIDS under-five and infant mortality are assessed by 
examining the assumptions made and reviewing relevant literature, and its impact on the 
resulting infant mortality is determined. Moreover, this study assesses the impact of the 
assumed life table on the IGME infant mortality rates of these countries. In doing so, 
the ratio of the infant mortality rates to the under-five mortality rates computed from 
the model life tables are compared with the ratios computed from projection estimates 
excluding HIV/AIDS mortality and empirical estimates corresponding to the period of 
no or low HIV. 
3.1.4 Estimation of the infant mortality rate using the Blacker and Brass and Keyfitz 
models 
The infant mortality rate is determined from the under-five mortality rate and neonatal 
mortality rate using the method proposed by Blacker and Brass (2005) and Keyfitz 
(1966), although these models are designed for estimating the l(x) values between ages 
one and five years, and not specifically under the age of one year. These methods 
require the estimates of the survival curve, l(x) at two different ages in order to 
determine the values of the coefficients of the equation (refer section 2.4.1 and 2.4.2 for 
details about the methods). The values of the survival curve at age of one month and 60 
months are used in this study to compute the values of the coefficients. Estimates either 
of the neonatal mortality rate or infant mortality rate can be produced using these 
models. However, the neonatal mortality rate determined from the infant mortality rate 
and under-five mortality rate using the models are more sensitive to errors in the infant 
mortality rate than the infant mortality rate (determined from neonatal mortality rate  
and under-five mortality rate) to errors in the neonatal mortality rate. Thus the models 
are used to assess only the infant mortality rates.    
The estimates of infant mortality rate computed by the IGME are compared with 
the estimates determined by using the method proposed by Blacker and Brass and 
Keyfitz. 
3.2 The method of assessment of the age pattern of mortality under five 
years of age 
As the under-five mortality rate (U5MR) declines the concentration of mortality in the 
early ages of life, especially during infancy, and in the neonatal period increases, and as 
the infant mortality rate declines the concentration of mortality in the neonatal period 
also rises, and vice-versa (Andreev 2011; Bicego, Chahnazarian, Hill et al. 1991). 











mortality level is very low (if the infant mortality rate is between 0.017-0.022), although 
it is not the case for the countries included in this study. The neonatal mortality rates 
(NMRs) and infant mortality rates (IMRs) determined by the IGME method for the 
countries included in this study are assessed by computing the ratio of NMR to U5MR, 
IMR to U5MR and NMR to IMR. Then the ratios of NMRs to U5MRs, IMRs to 
U5MRs together with the U5MRs computed by the IGME are plotted against the time 
to which the estimates refer. The ratios of NMRs to IMRs together with the IMRs 
determined by the IGME are also plotted against time. The plots are then assessed in 
order to see if the estimates of NMR and IMR determined by the IGME are consistent 
with the theory of the age pattern of mortality below five years of age. 
3.3 The method of assessment of the neonatal mortality rate 
3.3.1 Empirical assessment of the neonatal mortality rate 
The IGME estimates of neonatal mortality for Botswana, Malawi and South Africa are 
compared with estimates produced by other organisations and institutions. These 
mortality rates estimated by the IGME for countries under-study are also compared 
with the estimates obtained from the literature. Besides this, the IGME estimates of 
neonatal mortality rates for South Africa are compared with those of the estimates 
computed from the vital statistics data corrected for the level of completeness. The 
same procedure as in the case of under-five mortality and infant mortality rates is carried 
out to compare the neonatal mortality rates. 
3.3.2 Logical assessment of the neonatal mortality rate 
According to the IGME, the neonatal mortality rate is expressed as a quadratic function 
of the under-five mortality rate. However, HIV/AIDS which is one of the major cause 
of death causes of death for children between one month and five years is not a major 
direct cause of death for neonates (Lawn, Kerber, Enweronu-Laryea et al. 2010; Lawn, 
Wilczynska-Ketende and Cousens 2006). Thus the reasonableness and impact of relating 
















This chapter discusses the consistency of the IGME results of Botswana, Malawi and 
South Africa with other empirical results. Moreover, the reasonableness and the impact 
(on the IGME results) of the assumptions made in developing the IGME method are 
also discussed. Section 4.1 presents the comparison of the IGME under-five mortality 
rates of Botswana, Malawi and South Africa with other empirical results determined by 
different institutions, organisations and published results, and an assessment of the 
reasonableness and the impact of the assumptions made by the method in estimating 
the under-five mortality rates (logical assessment). Section 4.2 discusses the age pattern 
of mortality below the age of five years. The empirical and logical assessment of the 
infant and neonatal mortality rates are discussed in section 4.3 and 4.4.   
4.1 Assessment of the under-five mortality rate 
4.1.1 Empirical assessment of the under-five mortality rate 
4.1.1.1 Empirical assessment of the Botswana under-five mortality estimates  
The under-five mortality rates of Botswana produced by the IGME are compared with 
other empirical estimates, shown in Figure 4.1. According to this comparison the under-
five mortality rates of Botswana produced by the IGME are not significantly different 
from other empirical estimates except those determined by Garenne and Gakusi (2009) 
between 1980 and 1990. After 1990, while the IGME estimates increase rapidly and the 
deviation of the IGME results from those of the Spectrum, USCB and the IHME 
results get bigger with time, the IGME results on average approach the estimates 
determined by Garenne and Gakusi (2009) and the ASSA2003 estimates between 1990 
and 2002 (the IGME results increase from about 57 to 93 and those of the Spectrum, 
IHME and USCB increase from 64 to 82, 55 to 63 and 56 to 67 respectively in the same 
period as shown in Table B 1, Appendix B). The estimates of the ASSA2003 model may 
be exaggerated because of the fact that the model is somewhat out of date (personal 
communication with Rob Dorrington). Specifically, the IGME results are on average 
close to those of the ASSA2003 estimates between 1998 and 2002 in contrast to other 
estimates, which could suggest that the IGME results are overestimated during this 
period. This could be because the method used by IGME to produce these results 
ignore the impact of PMTCT which has had significant impact on the improvement of 











NACA 2010) or the estimation of the AIDS mortality by UNAIDS estimate. Beginning 
from 2003 the IGME estimates approach the estimates produced by others except the 
USCB and thus these results seem reasonable. In conclusion, the IGME under-five 
mortality rates of Botswana are consistent with other estimates between 1980 and 1997 
and after 2002, but are possibly too high between 1998 and 2002.                                      












year	  IGME Spectrum IHME
ASSA USCB Garenne&Gakusi	  2010  
4.1.1.2 Empirical assessment of the Malawian under-five mortality estimates  
Figure 4.2 shows the plot of the under-five mortality rates of Malawi obtained from 
different sources including estimates of Kanjala (2008) computed from the 1992, 2000 
and 2004 DHS full birth history data without correcting for the bias due to HIV/AIDS 
and the estimates obtained from the 2010 DHS report. According to this comparison, 
the IGME estimates are consistent with the estimates determined by others until 1998. 
However, the under-five mortality rates produced by the IGME from 1980 to 1998 are 
less than or equal to (lie between 214 and 182, shown in Table B 1, Appendix B) the 
under-five mortality rates computed from full birth history data not corrected for the 
bias due to HIV/AIDS (which are between 219 and 188). On the other hand, the 
prevalence of HIV in Malawi among women aged 15-49, obtained by standardising the 
ANC data for area and age is above 10%, according to Crampin, Glynn, Ngwira et al. 
(2003) and 9.5% according to Spectrum, since 1992. The under-five mortality rates 
computed from full birth history data without correcting the bias due to HIV/AIDS 
underestimate the true rates (Mahy 2003; Zaba, Marston and Floyd 2003). Therefore, 
the IGME under-five mortality rates of Malawi produced between 1992 and 1998 











data without correcting for the bias due to HIV/AIDS. Starting from early 2000 the 
difference between the IGME estimates and the estimates produced by the USCB and 
Spectrum gets bigger with time and the IGME results approach to the estimates 
obtained from the 2010 DHS (the IGME estimates are higher by 6%, 4% and 0.3% 
compared to the 2010 DHS estimates in the periods 10-15, 5-10 and 0-5 years before 
the survey, respectively), which suggests that the IGME results are probably understated 
to a certain extent between 1999 and 2010.    
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  period	  	  
IGME IHME
USCB 2010DHS
Spectrum Garenne	  and	  Gakusi	  2009
Kanjala	  2008   
4.1.1.3 Empirical assessment of the South African under-five mortality estimates 
Figure 4.3 shows the plot of the South African under-five mortality rates obtained from 
different sources, including those obtained from from the IHME (the quality of the 
2003 DHS data of South Africa is poor hence not used for assessing the IGME results). 
From this comparison the under-five mortality rates estimated by the IGME are close to 
the estimates produced by others between 1980 and 1993. Thereafter, the under-five 
mortality produced by the IGME increase at a faster rate and lie above the ASSA2008 
model estimates and empirical results computed by Darikwa (2009) and Nannan, 
Dorrington, Laubsher et al. (2012) from vital registration data corrected for 
incompletness, between 2000 and 2006. This could be due to errors in the data used for 
computing empirical results and the estimation of the AIDS mortality obtained from 
UNAIDS. However, the IGME under-five mortality rates do not deviate significantly 
from those of the ASSA2008 model and empirical estimates (deviates by 1% - 16% and 
1% - 9.6% from the ASSA2008 and empirical estimates respectively). Starting from 
2007 the under-five mortality rate produced by the IGME lie between the estimates 











models. Generally, the estimates of South African under-five mortality rates produced 
by the IGME  are consistent with the other empirical estimates.                        
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Thus generally, from the above comparisons it appears that the IGME estimates 
for South Afrca and Botswana are consistent with other empirical results except those 
of the estimates of Botswana between 1998 and 2003. The under-five mortality of 
Malawi produced by the IGME consistent with epirical results determined by others 
during periods of no or low HIV/AIDS epidemic (before 1992), afterwards the 
estimates appear to be biased downward. The reason is not apparent. It could be 
because the method used for correcting the bias in the under-five mortality rate due to 
HIV/AIDS computed from full birth history data may not work in countries like 
Malawi having high background mortality (mortality due to all other causes except 
AIDS) and/or errors in the data. 
4.1.2 Assessment of the impact of excluding the indirect under-five mortality rates 
by the IGME 
This section discusses the impact of IGME having excluded the indirect under-five 
mortality rates in the modelling process, on the under-five mortality produced for 
Malawi and South Africa. Botswana is not considered since it was not possible to get 
both the direct and the indirect under-five mortality rates computed from the same data 
source during the period of HIV epidemic. 
4.1.2.1 Comparison of the direct and the indirect under-five mortality rates of Malawi 
The comparison of the direct under-five mortality rates corrected for the impact of HIV 











corrected for the impact of HIV using the Ward and Zaba’s method, crudely adjusted 
(by taking the prevalence of HIV/AIDS at a time which the estimates refer) to allow for 
changes in the prevalence of HIV over time for Malawi, is shown in Figure 4.4. 
According to this figure, the direct and the indirect under-five mortality rates computed 
from the 2004 DHS and the 2006 MICS using the data from women in the middle of 
the reproductive age range are relatively close. However, there are notable differences 
between the under-five mortality rates determined using the direct and the indirect 
methods using the data from women at the youngest and oldest reproductive age 
groups. The discrepancy between the under-five mortality rates estimated using the 
direct and the indirect methods at the youngest and the oldest age groups could be due 
to biases in the data obtained from women in these age groups. Accordingly, the IGME 
assigns low weight to the under-five mortality rates computed using the data obtained 
from women in these age groups. However, there is a significant difference between the 
direct and the indirect under-five mortality rates computed from the 2000 DHS data. 
The direct estimates show a declining trend, which is consistent with other studies 
(Garenne and Gakusi 2009; Kanjala 2008), whereas the indirect estimates are virtually 
stable between 1989 and 1994 and increase after that. It is possible that this difference 
can be due to errors associated with the data used for computing the indirect estimates. 
Hence there is no significant difference between the direct and the indirect under-five 
mortality rates of Malawi. Thus, one cannot fault the IGME under-five mortality rates 
of Malawi for excluding the indirect under-five mortality rates corresponding to the 
period of high HIV/AIDS epidemic in the estimation process. 
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4.1.2.2 Comparison of the direct and the indirect under-five mortality rates of South Africa 
The indirect under-five mortality rates computed from the 1998 SADHS, crudely 
adjusted for the impact of HIV/AIDS using Ward and Zaba method, are higher than 
the corresponding estimates computed from the 1998 SADHS full birth history data, as 
shown in Figure 4.5 (the 2003 SADHS is excluded due to error in the data). This is 
because the Brass CEB/CS method overestimates the under-five mortality rates for 
countries having longer birth intervals, such as South Africa (Dorrington, Timaeus, 
Moultrie et al. 2004; Nannan, Timaeus, Laubscher et al. 2007). Thus the exclusion of the 
indirect under-five mortality rates of South Africa in the modelling process by the 
IGME probably resulted in better estimates.                      
Figure 4.5 The 1998DHS direct and indirect U5MRs corrected for the impact of HIV for 
















4.1.3 Logical assessment of the under-five mortality rate 
The IGME makes some assumptions in order to correct the bias introduced due to 
HIV/AIDS on the estimates of under-five mortality rates computed from full birth 
history data. The accuracy of the under-five mortality rates computed from full birth 
history data for countries affected by HIV/AIDS in general and Botswana, Malawi and 
South Africa in particular depend on these assumptions. The reasonableness and/or the 
impact of these assumptions are discussed in this sub-section.     
The method used by the IGME to produce these results assumes that 35 per cent 
of the births of HIV positive mothers are HIV-positive. This is the transmission rate of 
the virus from the mother to the child without PMTCT or ART (Department of Health 
South Africa 2012; NACA 2008). Thus the IGME method effectively assumes that the 
PMTCT programme doesn’t have an impact on child survival in general and on the 











in Kwazulu-Natal, South Africa by Rollins, Little, Mzolo et al. (2007) indicates that the 
transmission rate of HIV from mother to the child among women who use the PMTCT 
programme (use of single dose nevirapine) is less than 50% of women who do not. A 
report by the Department of Health South Africa (2012) reveals that as a result of the 
use of single dose nevirapine the national transmission rate of HIV reduced from a 
value 30% (in the absence of PMTCT) in 2001 to 12% in 2007. Another study 
conducted in Botswana by Stover, Johnson, Zaba et al. (2008) suggests that PMTCT 
resulted in a 66% reduction in the number of new infections in 2007 as compared to the 
number expected if the programme wasn’t introduced. According to reports (NACA 
2008; UNAIDS and NACA 2010), in Botswana the PMTCT programme was 
established in 1999 and the percentage of HIV positive women using PMTCT rose 
from 27% in 2002 to 94% in 2009. Therefore the failure to take into account the impact 
of the PMTCT programme produces an exaggerated number of children infected by 
HIV in Botswana. Thus the number of deaths of children due to HIV may be inflated, 
which correspondingly overstates the estimated number of unreported child deaths due 
to deaths of mothers because of HIV/AIDS. The direct under-five mortality rates 
(adjusted for the bias due to HIV) computed from the 2007 Botswana Family and 
Health Survey data could be exaggerated and may in turn overstate the IGME under-
five mortality rates especially, those in the early 2000s. The South African PMTCT 
programme was implemented at the national level during 2002 and the percentage of 
women using PMTCT reached 72% in 2006 (Frizelle, Solomon and Rau 2009; Ministry 
of Heath South Africa 2008). However, since the IGME did not use any direct under-
five mortality rates computed from full birth history data after 2003, ignoring the impact 
of PMTCT does not affect the IGME results. The PMTCT programme of Malawi was 
launched in 2003 and the uptake was low up to 2007 (Ministry of Health Malawi 2008). 
Hence the assumption of no impact of PMTCT may not exaggerate the estimate 
computed from the 2010 DHS survey referring the period 0-4 years before the survey 
date. This is because the PMTCT programme was expanded after 2007 and the survival 
of HIV-positive women who gave birth during this period was high. Hence the 
estimated number of unreported deaths of children due to death of their mothers 
because of HIV/AIDS is limited. Therefore, the IGME under-five mortality rates of 
Malawi are not affected as a result of not taking into account the impact of PMTCT 











The IGME also assumes that the mortality experience of HIV negative births is 
the same whether the children are borne by HIV-positive or HIV-negative mothers. 
However, studies indicate that HIV-negative births to HIV-positive mothers have a 
higher chance of dying than births from HIV-negative mothers (Adetunji 2000; Hallett, 
Gregson, Kurwa et al. 2010; Marston, Zaba, Salomon et al. 2005; Nakiyingi, Bracher, 
Whitworth et al. 2003). This is because of the indirect impact of HIV, such as the 
mother being sick or dead, on the survival of children of HIV-positive mothers. If we 
consider one impact, such as death of the mother, the likelihood of death of children 
less than three years old whose mothers have died is 6 times higher as compared to their 
counterparts, and the probability of dying of HIV-positive mothers is 12 times higher as 
compared to HIV-negative mothers (Zaba, Whitworth, Marston et al. 2005). In addition, 
a study conducted in Uganda by Newell, Brahmbhatt and Ghys (2004) suggests that 
there is a significant difference in mortality between HIV-negative children born to 
HIV-positive and HIV-negative mothers (166 and 128 per 1000 respectively). Hence the 
assumption (i.e. the mortality of HIV-negative children born to HIV-positive and 
negative mothers is similar) may understate the under-five mortality rates. However, this 
effect may be confined to periods of high HIV prevalence (above 10%) with no or 
limited use of ART. The ART programme was introduced to Botswana in 2001 and the 
percentage of people on ART reached 63% among those in need of ART during 2004 
(Campbell, Kereng, Malmborg et al. 2012). The Malawian and South African national 
ART programme rolled-out in 2004. In Malawi the percentage of people on ART 
among those in need reached 61% by 2006 (Harries, Zachariah, Jahn et al. 2009) and in 
South Africa it was expected to reach around 50% in 2008 (Nattrass 2006). Therefore, 
the IGME estimates for Botswana between 1994 and 2004, Malawi between 1993 and 
2005 and South Africa 1997 and 2007 could be understated.       
In addition, the IGME assumes that the under-five mortality rate of HIV-positive 
births is 0.625 irrespective of whether the infection occurred before or at delivery 
(perinatally) or through breastfeeding. However, the progression of the disease depends 
on the point at which the child becomes infected. Children infected perinatally have a 
much higher risk of dying than those infected postnatally (Marston, Becquet, Zaba et al. 
2011; Stover, Johnson, Hallett et al. 2010). Similar studies also indicate that the hazard of 
children dying from being infected with HIV before or at birth is more than two times 
of those infected postnatally (Becquet, Marston, Dabis et al. 2012; Fawzi, Msamanga, 











et al. 2004; Ngubane, Ndirangu, Newell et al. 2012). In addition, the assumption does not 
consider the impact of child treatment (use of ART and Cotrimoxazole) on the 
reduction of the mortality of HIV positive children until 2007. According to a study by 
Stover, Fidzani, Molomo et al. (2008) in Botswana, deaths of children due to HIV/AIDS 
have reduced from 3,000 in 2001 to 790 in 2007 as a result of using ART on HIV-
positive children. Thus the number of deaths of children due to HIV/AIDS could be 
inflated since the impact of treatment of children is ignored. Accordingly, the under-five 
mortality rates computed from full birth history data corrected for the bias due to 
HIV/AIDS may be overstated. Since the IGME model is fitted from these estimates, 
the under-five mortality rates produced by the IGME model could be exaggerated.          
A survival curve with median survival time of 9.5 years since infection obtained 
from cohort studies is used by the IGME in order to determine the mortality schedule 
of women 4 years after infection for all countries with general epidemic level. However, 
studies by Stover, Johnson, Zaba et al. (2008) and Isingo, Zaba, Marston et al. (2007) 
show that the median survival time of females since infection without the use of ART is 
about 11.5 years for most countries including those in Southern Africa. Moreover, the 
study by Isingo and others suggests that the median survival time of women is strongly 
correlated with age at infection with a hazard ratio of death of 1.06 as age increases by 
one year. A similar study conducted in Malawi suggests the median survival time of 
women infected in age groups 15-19, 20-24, 25-29, 30-34, 35-39, 40-44 and 45-49 is 
13.3, 12.8, 11.7, 10, 9.1, 8.4, and 6.6 respectively in the absence of ART (Shapira 2011). 
In addition, the probability of survival of women is significantly improved after they 
receive ART (de Olalla, Knobel, Carmona et al. 2002; Kitahata, Gange, Abraham et al. 
2009; Mahy, Lewden, Brinkhof et al. 2010; Rehle and Shisana 2003; UNAIDS and WHO 
2009) and hence the average survival after the onset of AIDS increases from four 
months to 50 months (Kilsztajn, Lopes, do Carmo et al. 2007). The under-five mortality 
rates corrected for the bias due to HIV/AIDS are determined from full birth history 
data assuming a median survival time of 9.5 years (the IGME assumption) and 11.5 
years using the IGME spreadsheet (developed by Hill and Walker and given to me by 
Rob Dorrington) in order to see if there is a significant difference between the under-
five mortality rates computed under the two assumptions. The under-five mortality rates 
prior to 5-9 and 10-14 years to the survey date (assuming the survey is conducted in 
2009) determined using the IGME assumption are higher by 8% - 10% and 5% - 11% 











Therefore, the above assumption (median survival time of 9.5 years) could inflate the 
under-five mortality rates produced by the IGME. 
4.2 Assessment of the age pattern of mortality below the age of five years 
The ratios of the IMR to U5MR and NMR to U5MR are expected to rise when the 
U5MR declines and decline when the U5MR increases for Botswana and South Africa, 
according to Figure 4.6 and Figure 4.7 respectively. Thus as the under-five mortality rate 
declines the concentration of mortality in the infant and neonatal period rises and vice-
versa. Therefore, the IGME estimates of neonatal, infant and under-five mortality rates 
of Botswana and South Africa are consistent with the theory of the age pattern of 
mortality below five years of age. 




















































The under-five mortality rate of Malawi is declining almost linearly over the 
period of observation and hence one would expect a rising trend for the ratio of IMR to 
U5MR and NMR to U5MR. However, the ratios remained virtually constant up to 1995 
and declined thereafter, as presented in Figure 4.8. The reason for having constant ratios 
up to 1995 could be because of the fact that when mortality is high the ratios may not 
necessarily rise following the decline in the under-five mortality. For example, Coale and 
Demeny suggests a constant value for 1a0 and 4a1 when the mortality is high (Andreev 
2011). Therefore, we cannot say that the IGME estimates are inconsistent with the 
theory of the age pattern of mortality.  





















The IGME infant and neonatal mortality rates are also checked to see if they are 
consistent with the theory of the age pattern of mortality, shown in Figure 4.9, Figure 
4.10 and Figure 4.11 respectively. According to the figures, a decrease in infant mortality 
rate is accompanied by a corresponding increase in the concentration of mortality in the 
neonatal period and vice-versa. Thus the IGME neonata mortality and infant mortality 
rates are consistent with the theory of the age pattern of mortality below one year of 
age. The reason for a strange jump of the ratio of NMR to IMR in 2004 -2005 for 
Botswana, shown in Figure 4.9, is not apparent however it could be due to a faster rate 
of redution in IMR as result of the use of ART and PMTCT as compared to NMR 























































































4.3 Assessment of the infant mortality rate 
4.3.1 Empirical assessment of the infant mortality rate 
4.3.1.1 Empirical assessment of the infant mortality rates of Botswana 
As can be seen from Figure 4.12, the infant mortality rates computed by the IGME are 
close to the estimates determined by others, especially to the estimates of USCB and 
ASSA2003 of Botswana between 1980 and 1989. After that, as in the case of the under-
five mortality rate, the IGME infant mortality moves together with the ASSA2003 
estimates (a model that may produce higher deaths since it is out of date) up until 1999 
and lie above all estimates produced by others between 2000 and 2003. The IGME 
result deviates from those of the IHME by 28% - 33% and Spectrum by 7% - 17%, and 
is higher especially between 1996 and 2002 (the IGME results are between 58 and 64 
while those of the IHME, USCB and spectrum are between 46 and 48, 35 and 29 and 
51 and 55 in the period, shown in Table B 2, Appendix B). Hence the estimates seem 
exaggerated in the specified period, which could be because it is estimated from the 
under-five mortality rate (U5MRs are exaggerated during this period) and/or the use of 
the UNAIDS model to estimate the number of infant deaths due to HIV. After 2003 
the IGME estimates are fairly close to those from the IHME and Spectrum and the 
estimates are probably reasonable. In conclusion, the IGME infant mortality rates are 
consistent with other estimates between 1980 and 1996 and after 2003, but are possibly 
too high between 1996 and 2003.     
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4.3.1.2 Empirical assessment of the infant mortality rates of Malawi 
The infant mortality rates of Malawi determined by the IGME are fairly close to the 











Table B 2, Appendix B. The IGME results (lie between 139 and 107) are also virtually 
the same as those of the estimates computed from full birth history data not corrected 
for the impact of HIV (which are between 137 and 103) by Kanjala (2008) between 
1985 and 1998. Studies (Mahy 2003; Zaba, Marston and Floyd 2003) indicate that the 
IMRs determined from full birth history data not corrected for the impact of 
HIV/AIDS are biased downward. Therefore, the infant mortality rates determined by 
the IGME between 1992 and 1998 are low (on average lower by 10%) since the 
prevalence of HIV/AIDS in Malawi among women in the childbearing age group is 
above 9.5 beginning from 1992, according to the estimates obtained from Spectrum and 
a study by Crampin, Glynn, Ngwira et al. (2003). The reason for low value of IMR in the 
specified period could be because of the estimation of the infant mortality rate from the 
under-five mortality rate, which is biased downward. Since 1998 the deviation of the 
IGME results from those of the USCB (8%-44% between 1998 and 2010) and 
Spectrum (18%-54% between 1998 and 2010) increase with time, and on average, the 
IGME results are close to the results of Kanjala (2008) and the 2010 DHS report 
(estimates not corrected for the impact of HIV) especially after 2006 and the IHME. 
Thus the estimates appear to be low from 2007 onwards.                      
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4.3.1.3 Empirical assessment of the South African infant mortality rates 
Figure 4.14 compares the South African infant mortality rates estimated by the IGME 
with estimates produced by others. According to this comparsion, the infant mortality 
rates estimated by the IGME are very close to the estimates produced by others 
between 1980 and early 1990s. After that,  the infant mortality rates rise, becoming close 











from the ASSA2008, 8%-12% from those estimates computed from vital statisitics data 
after adjusting for incompletness by Nannan, Dorrington, Laubsher et al. (2012) and 6-
13% from those estimates produced by USCB between 2000 and 2005. This could be 
because of the estimation of the infant mortality due to HIV from UNAIDS and/or 
due to errors in the data used for computing empirical results. Thereafter, the IGME 
estimates declined and become close to the other estimates except the ASSA2008 
(which could be because the ASSA2008 model assumes a higher rate of reduction of the 
transmission of the virus from the mother to child or the consideration of the impact of 
the impact of information and education campaigns and social marketing and treatment 
of STDs by the ASSA model unlike to other models), and hence the IGME estimates 
may be considered to be consistent with other empirical results.            
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In conclusion, based on the above comparsions the infant mortality rates 
produced by the IGME for Botswana and South Africa appear to be reasobale except 
the estimates for Botswana between 1996 and 2002. The Malawi infant mortality rates 
produced by the IGME are  consistent with other empirical estimates before 1990 and 
between 1999 and 2005, in the other periods the estimates appear to be biased 
downward. 
4.3.2 Comparison of the IGME infant mortality rates with estimates computed using 
the Blacker and Brass and Keyfitz methods 
This section discusses the comparison of the IGME results with those of the infant 
mortality rates determined from the neonatal mortality rates and under-five mortality 
rates using the Blacker and Brass and Keyfitz model for Botswana and South Africa. 











five mortality rate is low in the country unlike for South Africa and Botswana. 
According to Blacker and Brass (2005), when mortality is relatively lower during infancy 
than during childhood the model may not give accurate results (which is what the results 
(not shown) of Malawi showed). 
4.3.2.1 Comparison of the IGME infant mortality rates of Botswana with estimates computed using the 
Blacker and Brass and Keyfitz models 
The IGME infant mortality rate of Botswana and those estimated from the neonatal 
mortality rate (after removing the HIV trend in the neonatal mortality rate, see section 
4.4 for further detail) and under-five mortality rate using the Blacker and Brass and 
Keyfitz models are compared in Figure 4.15. According to this comparison, the IGME 
results are fairly close to those of the infant mortality rates determined using the Blacker 
and Brass model. The IGME infant mortality rates are also compared with those 
estimates of infant mortality rates determined using the Blacker and Brass model 
without removing the HIV trend in the neonatal mortality rate; the IGME results are 
very close to those determined by using the model except during the period of high 
mortality of children due to HIV/AIDS, suggesting that the IGME neonatal mortality 
rates are likely to be inflated 1998 and 2003.  
The IGME results lie significantly below (16-33% less) the results determined 
using the Keyfitz model, not only for Botswana but also for South Africa (not shown) 
(and hence this model was dropped from consideration for South Africa Figure 4.16), 
which could be due to the inappropriateness of that model in estimating the infant 
mortality rate from neonatal mortality rate and under-five mortality rate. Thus based on 
the above results the IGME estimates are consistent with those produced by Blacker 











Figure 4.15 The IMR determined by the IGME and using the Blacker and Brass and 
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4.3.2.2 Comparison of the South African infant mortality determined by the IGME with the results 
computed using the Blacker and Brass model 
The South African infant mortality rates produced by the IGME are very similar to 
those of the estimates computed using the Blacker and Brass model in both scenarios 
(neonatal mortality rate with and without the HIV trend), although the estimates 
determined without the HIV trend in neonatal mortality rate are relatively closer, as 
indicated in Figure 4.16. The fact that the South African IGME estimates are close to 
the infant mortality rates determined from neonatal mortality rate with the HIV trend 
during times of high HIV mortality unlike those of Botswana is probably because the 
South African under-five mortality rates are consistent with other empirical estimates, as 
discussed in section 4.1.1.3 unlike to those of Botswana in the specified time.            
Figure 4.16 The IMRs computed by the IGME and using the Blacker and Brass models 

























In general, according to the above results the infant mortality rates of South 
Africa and Botswana produced by the IGME appear to be consistent with the estimates 
determined using the Blacker and Brass model. The Blacker and Brass model works 
reasonably well in AIDS mortality settings and can give reasonably good results of 
infant mortality rate, which could be estimated from the neonatal mortality rate and the 
under-five mortality rate. 
4.3.3 Logical assessment of the infant mortality rate 
The IGME determines the non-AIDS under-five mortality rate by subtracting the AIDS 
under-five mortality rate determined by UNAIDS from the all-causes under-five 
mortality rate. The UNAIDS estimates the AIDS under-five mortality rate using the 
estimates/projections of the prevalence of HIV among women in the reproductive age 
group, the age specific fertility rate of HIV infected women, the transmission rate of 
HIV from the mother to the child and the survival rate of children infected with the 
virus. The reasonableness of the assumptions made by the UNAIDS to get the values 
for some of the parameters and the impact of some of these assumptions on the IGME 
mortality estimates are assessed below. 
The IGME uses the default Spectrum (4.64 Beta 7) results to estimate the number 
of children who died of AIDS. The default Spectrum assumes that the annual survival 
of infants on ART is 0.83 and for children aged one year and above the survival is 0.85 
in the first year of use of ART and 0.93 in subsequent years. A literature review 
conducted by Dabis and colleagues (Mahy, Lewden, Brinkhof et al. 2010) in low and 
middle income countries indicates that the annual chance of survival of infants on ART 
in the first year of use of ART is between 0.93 and 0.95 and the survival becomes 
between 0.91 and 0.92 in the second year of ART use. They also conclude that taking 
Cotrimoxazole together with ART reduced death by 33%, 16% and 1% in the first, 
second and third year of treatment respectively. As a result, Spectrum allows the user to 
enter the percentage or number of children using Cotrimoxazole and adjusts mortality 
accordingly. According to the above discussion and as can be seen from the Spectrum 
package, the default Spectrum assumes no Cotrimoxazole is provided. However, some 
countries use Cotrimoxazole, for example, in Botswana the use of Cotrimoxazole by 
HIV infected children was 5,475, 8,115, 8,830 and 9,858 in 2004, 2005, 2006 and 2007 
respectively. Calculating the deaths by entering those numbers in Spectrum and 
comparing with the deaths determined using the default spectrum results in; 5% - 9% 











2007. Therefore, deaths of children due to HIV produced by the IGME are likely to be 
overestimated in such situations, which in turn affect the non-AIDS child mortality 
from which the non-AIDS infant mortality rate is determined. For example, the ratio of 
the AIDS under-five mortality rate obtained from Spectrum to the all-cause under-five 
mortality rate using estimates of IGME for Botswana and South Africa ranges from 
48% - 62% and 47% - 57% between 2004 and 2007, whereas the corresponding ratios 
for infant mortality rate are between 9% - 18% and 8% - 19% for Botswana and South 
Africa respectively during the same period. Therefore the non-AIDS infant mortality 
rates computed from the non-AIDS under-five mortality rates are too low, which in 
turn underestimates the all-cause infant mortality rates. 
4.3.3.1 Assessment of the appropriateness of the West model life table for Botswana 
The IGME employ interpolation to determine the non-AIDS infant mortality from the 
non-AIDS under-five mortality using the West model life table for Botswana. Figure 
4.17 shows the plot of the ratio of the infant mortality to the under-five mortality 
compared with that computed from the West model life table, estimates from projection 
models excluding HIV/AIDS and empirical estimates corresponding to the period of 
no or low HIV/AIDS. The ratios computed from the estimates of the ASSA2003 
model, DHS1988 and USCB are on average lower by 7 per cent (when the under-five 
mortality rate is between 49 and 80 per 1000) as compared to those computed from the 
West model life table. The infant mortality rates are determined from the under-five 
mortality rates using the We t and the North model life table (the North model life table 
is close to the pattern revealed by the DHS 1988, ASSA2003 and USCB estimates); the 
infant mortality rates determined using the West model life table are higher by 7% - 
11% as compared to those determined using the North model life table when the under-
five mortality rate is greater than 49. When the under-five mortality rate is less than 49 
the ratio of the infant mortality rate to the under-five mortality rate computed from the 
North and West model are close and the values of the infant mortality rates determined 
from the under-five mortality rates using these models become virtually the same. 
Therefore the non-AIDS infant mortality rates interpolated from the non-AIDS under-
five mortality rates which are greater than 49 per 1000, using the West model life table 
appear to be slightly high. Thus, the all-cause infant mortality rate produced by the 
IGME for Botswana could be exaggerated as a result of the choice of the West model 
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4.3.3.2 Appropriateness of the North model life for Malawi 
Interpolation is applied by the IGME to determine the non-AIDS infant mortality of 
Malawi from the non-AIDS under-five mortality using the North model life table. The 
plot of the ratios of the infant mortality rates to under-five mortality rates against the 
under-five mortality rates of Malawi using the non-AIDS estimates of Spectrum, the 
USCB estimates corresponding to the period of no or low HIV epidemic, estimates 
determined by Kanjala (2008) from DHS data before the time of high HIV epidemic 
and the North model life tables are presented in Figure 4.18. Referring to this figure, the 
ratios of the infant mortality rates to the under-five mortality rates computed from the 
North model life tables lie in between and do not deviate significantly from the ratios 
computed from Spectrum although it assumes the South model and those determined 
from the USCB and Kanjala (2008). Thus the use of the North model life table probably 
does not have a big effect on the non-AIDS infant mortality and hence the infant 
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4.3.3.3 Assessment of the suitability of the West model life table for South Africa 
Figure 4.19 compares the ratios of the infant mortality rates to the under-five mortality 
rates computed from empirical results corresponding to the period of low or no HIV 
epidemic and the non-AIDS estimates determined from projection models with those of 
the ratios computed from the West model life tables. According to this comparison, the 
ratios of the infant mortality rates to the under-five mortality rates computed from the 
West model life tables are not significantly different from those of the ratios computed 
from projection models and empirical results. Therefore the IGME infant mortality 
rates for South Africa especially those of the non-AIDS infant mortality rates, are not 
particularly affected by the choice of the West model life table.                
Figure 4.19 Ratio of the IMR to U5MR plotted against the U5MR using values of the 
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Generally, the use of the West model life table for South Africa and the North 
model life table for Malawi does not affect the non-AIDS infant mortality determined 
from the corresponding non-AIDS under-five mortality rate using techniques of 
intepolation, and hence the all-cause infant mortality rates produced by the IGME for 
these countries are not much affected by the use of those model life tables. However, 
the infant mortality rates of Botswana produced by the IGME appear to be inflated a 
little as a result of the use of the West model life table, especially when the non-AIDS 
under-five mortality rate is greater than 49. 
According to the empirical and logical assessments and the results of Blacker and 
Brass model, the South African infant mortality rates determined by the IGME appear 
to be  consistent with the estimates produced by othes over the period of observation. 
The infant mortality rates determined by the IGME for Botswana between 1980 and 
1995 and after 2002 are consistent with other empirical results. However, those 
estimates corresponding to the period between 1996 and 2002 appear to be inflated. 
Similarly, the Malawian IGME infant mortality rates corresponding to the period 
between 1992 and 1998 and after 2006 appear to be low; otherwise, the estimates  are 
consistent with other empirical results.  
4.4 Assessment of the neonatal mortality rate 
4.4.1 Empirical assessment of the neonatal mortality rate 
4.4.1.1 Empirical assessment of the neonatal mortality rates for Botswana 
Figure 4.20 compares the neonatal mortality rates computed by the IGME and the 
IHME for Botswana between 1990 and 2009. The IGME estimates are higher than the 
estimates computed by the IHME over the period of observation. However, the 
difference between the IGME and the IHME estimates is not material in the first five 
and last five years of the period of observation. During the period (1995 to 2004) of 
high HIV/AIDS epidemic with no or limited use of ART the IGME neonatal mortality 
rates rises quickly (from a value of 26 to 31, shown in Table B 3, Appendix B) while the 
IHME results remain fairly stable at a value of about 22, and the discrepancy between 

























4.4.1.2 Empirical assessment of the neonatal mortality rates of Malawi  
Figure 4.21 presents the neonatal mortality rates produced by the IGME, the IHME, 
MICS 2006 and those obtained from DHSs conducted between 1992 and 2010 for 
Malawi. The neonatal mortality rates estimated by the IGME are very close to the 
estimates of the IHME, although the IGME estimates are higher by 10-12 per cent 
between 2002 and 2007. In addition, the IGME neonatal mortality rates are more or less 
consistent with the estimates obtained from MICS 2006 and DHSs reports especially 
after 1994 although the neonatal mortality rates computed from the 2004 DHS data 
referring to periods 0-4 and 5-9 years before the surveys date. This is because those 
estimates (computed from the 2004 DHS data) referring to periods 0-4 and 5-9 years 
before the surveys data are widely considered to be underestimated and overestimated, 
respectively due to misclassification of year of death (Zimba, Kinney, Kachale et al. 
2012). Thus taki g this into account, the neonatal mortality rates of Malawi computed 











 Figure 4.21 The neonatal mortality rates determined by the IGME, IHME and DHS 
 
4.4.1.3 Empirical assessment of the South African neonatal mortality rates 
The South African neonatal mortality rates produced by the IGME are not significantly 
different from those computed from the 1998 SADHS and vital statistics data corrected 
for the level of incompleteness unlike the results of IHME between 1990 and 1998, 
presented in Figure 4.22. Between 1998 and 2004, the IGME neonatal mortality rates 
rise slightly from a value of 20 to 22, shown in Table B 3, Appendix B  (like the under-
five mortality rates) whereas those computed from the 2003 DHS and vital statistics 
data decline from 18 to a value of about 14 (which is unlikely to be due to error in the 
vital statistics data since the quality of the data are getting better with time (Nannan, 
Dorrington, Laubsher et al. 2012)), which is an indication of a problem in the IGME 
results in this period. After that, the IGME results decline while the results from the 
vital statistics data and IHME (after 2004) remain stable and the discrepancy from these 
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Generally, the IGME neonatal mortality rates of Botswana and South Africa rise 
and follow the pattern of the under-five mortality rates during the period of high 
mortality of children due to HIV/AIDS. However, most studies suggest that there is no 
significant association between the mortality of infants during the neonatal period and 
the HIV/AIDS epidemic (Bloland, Wirima, Steketee et al. 1995; Bourne, Thompson, 
Brody et al. 2009; Brocklehurst and French 1998; Kennedy and Fawcus 2012; Kim, 
Mwiya, Kankasa et al. 2011; Rollins, Little, Mzolo et al. 2007). Thus the increase in the 
value of the IGME neonatal mortality rates following the epidemic of HIV/AIDS could 
be due to the estimation of neonatal mortality rates from under-five mortality rates 
using the model that relates neonatal mortality rates and under-five mortality rates. 
Therefore, the IGME estimates in these countries are too high and are inconsistent with 
the estimates produced by others during the period of high HIV/AIDS epidemic. 
However, since the IGME under-five mortality rate of Malawi is almost the same as the 
under-five mortality rate not corrected for the bias due to HIV/AIDS, the IGME 
neonatal mortality rate determined from it is consistent with the empirical estimates 
determined by others.  
4.4.2 Logical assessment of the neonatal mortality rate 
The causes of death of children under the age of five years are broadly categorised as 
being due to endogenous or exogenous factors (Andreev 2011; Bourgeois-Pichat 1951; 
McDaniel 1981; Stockwell, Swanson and Wicks 1988). The endogenous causes are 
related to biological or genetic factors and foetal health, whereas the exogenous causes 
are those mostly related to environmental or external causes such as communicable 
diseases, parasites and accidents (Bourgeois-Pichat 1951; Kaushik, Parmar, Grover et al. 











of neonates are mostly due to endogenous (Andreev 2011; Karkal 1985) and the 
exogenous causes are the most important causes of death of children older than one 
month (Karkal 1985; Stiegler 2009). On the other hand in developing countries the 
exogenous causes are also important causes of death of children in the neonatal period 
with the exception of HIV/AIDS and Malaria (Lawn, Cousens and Zupan 2005; Lawn, 
Wilczynska-Ketende and Cousens 2006), and as mortality declines the endogenous 
causes become increasingly important causes of death for neonates (Andreev 2011). 
Similarly, studies by Bloland, Wirima, Steketee et al. (1995); Kazembe and Mpeketula 
(2010); Ticconi, Mapfumo, Dorrucci et al. (2003); Villamor, Msamanga, Aboud et al. 
(2005) indicate that unlike in the case of children between one month and five years, 
HIV/AIDS is not a major direct cause of death of children in the neonatal period. Thus 
one can conclude that the neonatal mortality is insensitive to or is not significantly 
affected by the epidemic of HIV/AIDS. The proportion of child deaths due to 
HIV/AIDS was between 48% to 15%, 16% to 13% and 36% to 28% between 2000 and 
2010 in Botswana, Malawi and South Africa respectively (UNICEF 2012). Thus, unlike 
in the neonatal period, HIV/AIDS largely determines the survival of children older than 
one month and it is the main reason for the reversal of the downward trend in child 
mortality for countries affected by HIV/AIDS (Adetunji 2000; Amouzou and Hill 2004; 
Campbell, Kereng, Malmborg et al. 2012; Garenne and Gakusi 2009; Sartorius, Kahn, 
Vounatsou et al. 2010). Therefore, relating the neonatal mortality and the under-five 
mortality (that contains the HIV trend), doesn’t make much sense, which could lead to 
the neonatal mortality rates produced by the IGME from the under-five mortality being 
inconsistent with the results produced by others, at least for countries experiencing high 
HIV/AIDS with low background mortality.  
  According to the empirical and logical assessments, the South African neonatal 
mortality rates determined by the IGME between 1990 and 1998, and those of 
Botswana between 1990 and 1994 and after 2004 are consistent with other empirical 
estimates. However, the estimates of South Africa in the period after 1998 and 
Botswana between 1995 and 2004 appear to be exaggerated and have the HIV trend. 
The neonatal mortality rates of Malawi computed by the IGME are consistent with the 












5 DISCUSSIONS AND CONCLUSIONS  
5.1 Introduction  
The main purpose of this study was to assess the methods of estimating the infant and 
neonatal mortality rates employed by the Inter-agency Group for Child Mortality 
Estimation in countries affected by HIV/AIDS using Botswana, Malawi and South 
Africa as a case study. In the process the study also assessed the method of estimating 
the under-five mortality rate since the neonatal and infant mortality rates are determined 
from the IGME under-five mortality rates. This chapter discusses the extent to which 
the research objectives have been met, what conclusions can be drawn and indicates 
further areas of research. 
Due to the absence or incompleteness of vital registration data in developing 
countries, especially those in sub-Saharan Africa, countries in the region depend on 
survey data for the measurement of mortality below the age of five years. The level and 
trend of mortality rates below the age of five years computed from a variety of sources 
may differ due to differences in the estimation methods and/or differences in the 
quality of the data obtained from different sources and hence cause difficulty in 
identifying the trend of mortality under the age of five years in these countries. 
Sometimes, it may not be possible to get a reliable estimate of mortality for finer age 
divisions since the data used for computing mortality in these are affected by errors; it 
may not even be possible to get the rates because some surveys do not collect the 
required data. Accordingly, the IGME has developed methods for estimating the level 
and pattern of under-five mortality using under-five mortality rates computed from 
different survey data and also estimates the level and pattern of neonatal mortality rate 
and infant mortality rate from the under-five mortality rate. Currently the estimates 
determined by these models are widely used for appraising the achievement of MDG4 
and resulting policies. However, no study has been conducted for assessing the details 
of these methods and this motivates the need to conduct this study. 
5.2 Assessing the IGME methods  
The IGME results of Botswana, Malawi and South Africa were compared with other 
estimates from population projection models and empirical results to determine if the 
IGME results are consistent with other empirical results. Moreover, relevant literature 











made by the method, since there is no “gold standard” against which the results could 
be assessed. 
The under-five mortality rates determined by the IGME method for the countries 
under study follow a similar trajectory of other empirical results, as shown by plotting 
their results with other empirical estimates of the countries included  in the study (see 
Figures 4.1, 4.2 and 4.3), except the trajectory of the estimates of Botswana and South 
Africa, determined by Garenne and Gakusi (2009) after the peak in the under-five 
mortality during the period of high HIV/AIDS epidemic, and the IHME estimates of 
South Africa during the period of high mortality of children due to HIV/AIDS. Though 
the empirical results follow similar trajectories, before the HIV/AIDS epidemic the 
results obtained from the different sources were close. Whereas after the HIV/AIDS 
epidemic the disparity between the results obtained from the different sources has 
increased which is the result of differences in assumptions and computation methods 
for correcting the bias in the results due to HIV/AIDS.     
A closer assessment of the IGME method for estimating the under-five mortality 
rate indicated that the method appears to produce estimates that are consistent with 
other estimates of under-five mortality rate for South Africa over the period of 
observation and for Botswana between 1980 and 1998 and after 2003; while between 
1998 and 2003 the under-five mortality rates of Botswana appear to be overestimated. 
The PMTCT programme in Botswana was introduced in 1999 and 27%, 37%, and 89% 
of HIV positive women used PMTCT in 2002, 2003 and 2007, respectively (NACA 
2008; UNAIDS and NACA 2010). Moreover, the ART programme of Botswana was 
established in 2001 and about 72% of HIV-positive children among those in need were 
receiving ART by about 2006. However, the method used by the IGME to produce 
these results assumes that ART didn’t have an impact on child survival before 2007 and 
that HIV transmission from mother to child was not reduced because of PMTCT. The 
assumptions of no impact of ART before 2007 on the survival of children and PMTCT 
on the reduction of HIV transmission by the IGME method may have inflated the 
under-five mortality rates computed from the 2007 Botswana Family and Health Survey 
data for the period between 1998 and 2003. However, these assumptions may not have 
an impact on the South African IGME under-five mortality rates because the 
percentage of people on ART was low before 2008 and no survey data after 2003 has 
been used by the IGME. This could be the reason why the IGME appear to be 











generalised assumption regarding the impact of interventions on child and maternal 
survival should not be made among countries since the time of the introduction and the 
use of the interventions differ between countries. The under-five mortality rates of 
Malawi are consistent with empirical results produced by others before 1991, although 
since 1992, during periods of high HIV prevalence, the method appears to 
underestimate the results which could be due to the reason mentioned in section 4.1.1. 
Thus one can suggest that for countries having low background mortality and affected 
by HIV/AIDS the IGME method produces results that are consistent with other 
empirical estimates. However, if the percentage of people on PMTCT and ART is high 
before 2007 the method may produce inflated results during the period of high 
mortality of children due to HIV/AIDS. Therefore, those who are interested in 
interpreting the level and pattern of the under-five mortality in these countries using 
estimates of the IGME should consider the level of use of ART and PMTCT in the 
country. While the method appears to underestimate the under-five mortality rate of 
countries affected by HIV/AIDS and having high background mortality during the 
period of high HIV/AIDS as shown in the case of Malawi and hence the results should 
be rejected. However, further research should be conducted in countries affected by 
HIV/AIDS and having high background mortality in order to strengthen this 
conclusion.   
Mortality rates that are wrong may lead to wrong policy decisions and planning. 
Inflated under-five mortality may lead to, for example, misinterpretation of the impact 
of those interventions implemented for improving child survival, or to underestimation 
of a school age population in the future and hence results in wrong planning such as the 
construction of less number of schools, training too few teachers and printing too few 
text books. In addition reduction of child mortality may be given a higher priority and 
hence more health facilities may be established, resources may be invested on child 
immunization and improvement of maternal health. The converse is true when under-
five mortality is underestimated.  
It was also shown that the assumptions of same under-five mortality rate for 
HIV-positive births regardless of whether the infection occurred perinatally or 
postnatally and a median survival time of 9.5 years since infection for HIV positive 
mothers in order to determine the mortality schedule of women, by the IGME method 
may overstate the under-five mortality rates. However, the impact of these assumptions 











This could be because the over adjustment due to the above assumptions is 
counteracted by other assumptions, such as similar mortality of HIV-negative births 
irrespective of the HIV status of the mother. 
The assessment of whether to exclude the indirect under-five mortality rates by 
the IGME method in the modelling process during the period of high HIV/AIDS 
prevalence is determined by comparing the direct and the indirect under-five mortality 
rates. The comparison is made after correcting the direct and the indirect under-five 
mortality rates for the bias due to HIV/AID, using the Hill and Walker method and the 
Ward and Zaba method crudely adjusted to allow for changes in the prevalence of HIV 
over time respectively. According to this comparison, the direct and the indirect under-
five mortality rates for Malawi are not significantly different and hence the exclusion of 
the indirect under-five mortality rates does not affect the IGME results for Malawi. The 
indirect under-five mortality rates of South Africa are significantly higher than the direct 
under-five mortality rates. However, the exclusion of the indirect under-five mortality 
rates by the IGME probably resulted better estimates because studies (Dorrington, 
Moultrie and Timaeus 2004; Nannan, Timaeus, Laubscher et al. 2007) indicate that the 
indirect method produces exaggerated results for South Africa. 
The IGME infant mortality rates which are estimated from the under-five 
mortality rates are affected by problems in the under-five mortality rates. For example, 
the infant mortality rates of Botswana between 1996 and 2003 are too high, like the 
under-five mortality rates in the corresponding period. Similarly, the infant mortality 
rates of Malawi between 1992 and 1998 and after 2006 are too low because the under-
five mortality rates in the corresponding periods are too low. Since there is no problem 
in the IGME under-five mortality rates of South Africa, the infant mortality rates 
computed from them appear to be consistent with the results produced by others. This 
suggests that the IGME method produces infant mortality rate from the under-five 
mortality rate that are consistent with the results produced by others if there is no 
problem in the under-five mortality rate. Thus one should consider the reasonableness 
of the under-five mortality rates before interpreting the level and pattern of the infant 
mortality rates obtained from the IGME.       
The infant mortality rates are computed using the Blacker and Brass method from 
the neonatal mortality rate (after removing the HIV trend in the neonatal mortality rate) 
and the under-five mortality rate for Botswana and South Africa. The IGME results of 











Blacker and Brass method for the respective countries. This model is not able to 
indicate the problem in the IGME result of Botswana between 1996 and 2003, unlike 
that indicated using the empirical results, because it computes the results from the 
under-five mortality rate (the under-five mortality rate is high during the corresponding 
period). Also the ratios of infant mortality rates to under-five mortality rates computed 
from the West and North model life tables are close to the ratios computed from the 
non-AIDS empirical results of South Africa and Malawi respectively, and thus the 
choice of the West and North model life tables to represent the non-AIDS mortality 
pattern below the age of five years for South Africa and Malawi respectively, probably 
do not distort the infant mortality rates of South Africa and Malawi. However, the ratios 
of the infant mortality rates to under-five mortality rates computed from the West 
model life tables are higher on average by about 10% as compared to the ratios 
determined from the non-AIDS empirical results when the under-five mortality rates are 
between 49 and 80 per 1000. Thus the choice of the West model life table results in 
slightly higher (7% - 11%) non-AIDS infant mortality rates as compared to those 
determined using the North model life table, which is closer to the ratios computed 
from the non-AIDS empirical estimates. 
The study also indicated that the assumption that no Cotrimoxazole is provided to 
HIV-positive children exaggerates both infant and child deaths due to HIV/AIDS. This 
in turn understates the non-AIDS under-five mortality, which is determined by 
subtracting the under-five mortality due to AIDS from the all-cause under-five mortality 
determined by the IGME. Therefore, the non-AIDS infant mortality estimated by the 
IGME from the non-AIDS under-five mortality is understated. In order to determine if 
the addition of the over adjusted AIDS infant mortality corrects the lower adjusted non-
AIDS infant mortality and hence the IGME method produces infant mortality rates that 
are consistent with the results produced by others, the percentage of AIDS infant 
mortality to the all-cause infant mortality and the AIDS under-five mortality to the all-
cause under-five mortality were compared. According to this comparison, the 
percentage of AIDS under-five mortality to the all-cause under-five mortality is between 
47% and 62%, whereas the percentage of AIDS infant mortality to the all-cause infant 
mortality is between 8% and 19% during the period 2004 to 2007 for Botswana and 
South Africa. Thus the assumption of no Cotrimoxazole is provided to HIV-positive 
children understate the IGME infant mortality rates. Therefore, the IGME should get 











HIV/AIDS, and considers its impact on the estimation of deaths of children due to 
HIV/AIDS.  
   The IGME method produces neonatal mortality rates that have the HIV trend 
and are higher than the true rates for countries having low background mortality and 
affected by the HIV/AIDS epidemic, as indicted in the case of Botswana and South 
Africa. Before the period of the HIV/AIDS epidemic the method appears to produce 
results that are consistent with other independent empirical estimates. The proportion 
of child mortality due to AIDS reduced at a relatively faster rate in Botswana (from 48% 
to 16% between 2000 and 2010) than in South Africa (from 36% to 28% over the same 
period) (UNICEF 2012). This could be the reason why the IGME neonatal mortality 
rates of Botswana are consistent with other empirical results, while those of South 
Africa are not, during the period of declining AIDS-specific child mortality, after the 
early 2000s. As indicated by studies (Bloland, Wirima, Steketee et al. 1995; Bourne, 
Thompson, Brody et al. 2009; Kennedy and Fawcus 2012; Nannan, Dorrington, 
Laubsher et al. 2012) HIV/AIDS is not a direct major cause of children in the neonatal 
period. Therefore, the increase in under-five mortality following the HIV/AIDS 
epidemic in countries affected by HIV/AIDS is because of deaths of children older 
than one month due to HIV/AIDS. Thus the IGME method for estimating the 
neonatal mortality rate, tries to relate deaths which have some unrelated causes. This 
could be the reason why the IGME neonatal mortality rates of Botswana and South 
Africa are higher and have the HIV trend during the period of high HIV/AIDS 
prevalence. The IGME neonatal mortality rates for Malawi, also determined from the 
under-five mortality rates, are not significantly different from other empirical estimates 
of the neonatal mortality rate and the impact of HIV/AIDS is not very apparent in the 
estimates, and hence the IGME neonatal mortality rates appear to be consistent with 
estimates produced by others. This could be because the under-five mortality rates of 
Malawi determined by the IGME model are virtually the same as those not corrected for 
the bias due to HIV/AIDS, or due to lower level of adult HIV prevalence in the 
country and hence lower proportion of child deaths due to HIV/AIDS (for example, 
the proportion was between 13% in 2010 and 16% in 2000 (UNICEF 2012). Therefore, 
the results can be used for designing programmes and formulating policies that focus on 
the survival of neonates. Though the IGME neonatal mortality rates of Malawi are 
consistent with other results at the moment; the method may not produce neonatal 











IGME under-five mortality rate of Malawi during the period of high HIV/AIDS is 
adjusted. From the above discussions one can conclude that the AIDS-related mortality 
that exists in the under-five mortality rate should be removed before estimating the 
neonatal mortality rate from it for countries affected by HIV/AIDS. This is because the 
exogenous cause of death (such as communicable diseases, especially HIV/AIDS) of 
children under the age of five are high in these countries hence the estimation of the 
neonatal mortality rate from the under-five mortality rate may inflate the results.        
5.3 Limitation of the study 
The IGME methods for producing the estimates of under-five mortality, infant 
mortality and neonatal mortality rates are assessed using estimates from projection 
models and empirical results from survey and vital statistics data. However, the 
projection estimates have their own limitations and are largely dependent on the 
assumptions made in developing the models (Andreassen 1992; National Research 
Council 2000; Rowan and Wright 2010). The empirical results are affected by the quality 
of survey data, which are mostly affected by coverage, response and sampling errors. 
Moreover, the assumptions made by the methods used for computing empirical results 
from survey data and projection models are affected by the HIV/AIDS. Thus there is 
uncertainty around the estimates from projection models and empirical results and the 
uncertainty increases after the HIV/AIDS epidemic. Hence it is difficult to draw strong 
conclusions about the reasonableness of the IGME under-five mortality and infant 
mortality rates especially after the period of the HIV/AIDS epidemic.      
The empirical results used for validating the neonatal mortality rates are very few. 
For example, for Botswana only the results of the IHME are used and for South Africa 
the empirical estimates of Nannan, Dorrington, Laubsher et al. (2012) is used to validate 
the IGME neonatal mortality rates between 2000 and 2006. Thus the strength of the 
conclusions made about the estimates of neonatal mortality for Botswana over the 
period of observation and that for South Africa between 2000 and 2006 is in question. 
This study fails to determine the net effect of the assumption that overstate 
(similar mortality of HIV-positive births regardless of whether the infection occurred 
perinatally and postnatally and no impact of ART before 2007) and understate (similar 
mortality of HIV-negative births irrespective of the HIV status of the mother) the 
under-five mortality rate computed from full birth history data on the IGME results, 
and concluded that those assumptions that overstate the results could be counteracted 











5.4 Scope for further research 
The IGME fitted a regression model to the neonatal mortality and the under-five 
mortality rates computed from survey and vital registration data obtained from all 
developing countries having incomplete or no vital registration data, regardless of the 
prevalence of HIV/AIDS in the country. The regression coefficients obtained from this 
model are used to estimate and project the pattern and level of neonatal mortality rates 
for all developing countries. The impact of using the same regression coefficients for all 
countries regardless of the HIV/AIDS epidemic is not determined in this research. 
Thus, further research should be conducted in order to ascertain the impact of using the 
same regression coefficients on the resulting neonatal mortality rates by fitting different 
regression models for countries affected by HIV/AIDS and those not affected by 
HIV/AIDS. 
This study assesses the validity of the IGME methods, especially for those 
countries affected by the HIV/AIDS epidemic and may not be applicable to the IGME 
methods in countries not affected by the epidemic. Thus it is important to conduct a 
similar study to assess the validity of the IGME methods in these countries. 
The HIV prevalence rate in Malawi was above 9.5 in 1992. However, the infant 
mortality rates of Malawi determined by the IGME between 1992 and 1998 and after 
2006 are virtually the same as the infant mortality rates not corrected for the bias due to 
HIV/AIDS. Thus this study argues that the IGME infant mortality rates appear to be 
underestimated. In order to quantify the deviation of the IGME results from the infant 
mortality rates computed from full birth history data corrected for the bias due to 
HIV/AIDS, first the under-five mortality rates are determined using the Hill and Walker 
method, and then the infant mortality rates are interpolated from the resulting under-
five mortality rates using the Coale and Demeny model life table. The reason for doing 
all these steps is that the Hill and Walker method corrects only the bias due to 
HIV/AIDS in the under-five mortality rates. This method therefore has to be extended 
to estimate the infant mortality rates corrected for the bias due to HIV/AIDS. 
 The assumptions of same mortality for HIV-positive births regardless of whether 
the infection occurred perinatally or postnatally and a median survival time of 9.5 years 
since infection for HIV positive mothers in order to determine the mortality schedule of 
women by the IGME method may overstate the IGME under-five mortality rate. 
Similarly, the assumption of same mortality of HIV-negative births regardless of the 
HIV status of the mothers by the IGME method may understate the IGME under-five 











the IGME under-five mortality rates cancel out to some extent. However, the extent of 
the cancellation is uncertain. Thus, further research should be conducted to quantify the 
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APPENDIX A: The pattern of mortality below five years of age in developing countries     
      relative to the pattern in common model life tables  
The ratios of infant to under-five mortality computed using data from fourteen 
countries in the Near East, North Africa, Asia, Latin America and the Caribbean, lie 
between those of the North (highest ratios) and the Chilean (lowest ratios) model life 
tables (figure not included) (Sullivan, Rutstein and Bicego 1994). Figure A 1 shows the 
plot of the ratios of infant to under-five mortality computed from DHS data collected 
between 1985 and 1990 in twelve Sub-Saharan countries compared to the North and 
Chilean model life tables. Only the ratios from countries having a low level of mortality 
during the time of the survey, such as Botswana, Kenya and Zimbabwe, lie within the 
plot of the North and Chilean model life tables. The ratios for the remaining countries 
except Liberia, having high mortality lie below the plot of the North model life table. 
Thus in high mortality countries of Sub-Saharan Africa there is a relatively higher 
concentration of deaths between ages one and five years as compared to countries in the 
developing region (Sullivan, Rutstein and Bicego 1994) and other developing countries. 
In addition, in sub-Saharan countries a high level of mortality extends to the age range 
between two and five years instead of being limited between age zero and two years. 
The above facts are, therefore, evidence that the mortality experience of sub-Saharan 
population below the age of five years is not represented by the Coale and Demeny and 











        Figure A 1 The ratio of IMR to U5MR against the U5MR computed from the North 
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Appendix B Under-five, infant and neonatal mortality rates obtained from various 
sources for the countries studied 
Table B 1 Under-five mortality rates for Botswana, Malawi and South Africa obtained 
from various sources 
 Botswana Malawi 
year  IGME  spectrum IHME ASSA Garenne 
&Gakusi 






1980.5 80.8 93.55  85.10 65.82 254.4 263.5 275  282.39  1980.3 259.3 
1981.5 76.8 90.05  81.71 62.79 248.2 258.9 272  274.80  1982.4 215.3 
1982.5 72.9 86.65  78.46 59.90 243.7 254.4 268  267.33  1983.2 251.8 
1983.5 69.3 83.35  75.36 57.13 240.6 250.4 262  260.00  1985.3 246.6 
1984.5 65.9 80.1  72.41 54.48 238.4 247 256  250.09  1987.4 214.6 
1985.5 63 77  69.66 51.94 236.4 243.7 250  246.92  1988.2 247.4 
1986.5 60.8 74.1  67.20 49.52 234.8 240.6 245  243.78  1990.3 233.8 
1987.5 58.9 71.4  65.15 47.21 232.2 237.6 239  240.67  1992.4 189.7 
1988.5 57.5 68.9  63.73 49.85 230 232.7 233  237.58  1993.2 219.6 
1989.5 57.5 66.65  63.27 52.64 226 226.2 228  234.52  1997.4 186.8 
1990.5 58.7 64.75 55.2 64.08 55.57 222.1 220.6 223 209.8 231.49  1998.2 188.6 
1991.5 60.6 63.25 56.4 66.51 58.65 218.1 215.4 219 205.8 228.49  2002.4 133.4 
1992.5 63.2 62.75 57.8 70.82 61.90 214.7 210.4 215 201.6 225.92    
1993.5 66.6 63.8 59.2 76.78 65.31 212.5 205.8 212 197.2 216.27    
1994.5 70.9 65.95 60.7 83.64 68.90 209.3 201.4 209 192.3 206.93    
1995.5 76.1 68.75 62.1 90.49 72.66 205.1 197.2 206 187 197.88    
1996.5 81.7 72.05 63.5 96.55 76.62 199.4 193.1 203 181 189.14    
1997.5 87.2 75.6 64.6 101.38 80.77 191.1 188.7 200 174.4 180.70 180   
1998.5 91.9 79.1 65.3 104.86 85.13 182.6 184.5 197 166.8 172.55    
1999.5 94.9 81.65 65.5 106.55 89.70 174.5 180.6 193 158.4 164.70    
2000.5 95.9 82.75 65.1 104.18 94.49 166.5 176.2 190 149.5 157.14    
2001.5 95.4 83 64.4 97.27 99.50 158.7 171.4 186 140.6 149.86    
2002.5 93.1 82.25 63.3 87.20 104.76 150.9 166.5 182 132.3 142.86 145   
2003.5 87.9 81.15 62.1 74.58 110.25 143.4 161.7 178 125 136.14    
2004.5 70.4 80.85 60.6 63.46 116.00 135.7 156.8 174 119 129.68    
2005.5 60.9 78.95 59 59.20 122.01 128.1 151.8 170 114.3 123.49    
2006.5 54.9 72.25 57.2 58.70  120.4 146.2 165 110.7     
2007.5 52.4 64.8 55.1 58.30  112.4 139.9 160 107.9  112   
2008.5 51.8 60.95 52.9 57.72  104.7 134.4 156 105.6     
2009.5 49.4 58.8 50.7 56.69  98.1 130.6 152 103.6     
2010.5 47.7 54.95 48.6 55.50  92.1 127.1 147 101.8     
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1980.5 89.2 90 
    
97.84771 63.9 
 
1981.5 85.5 86.8 
    
92.39594 73.4 
 
1982.5 81.9 83.7 
    
87.21855 72.5 
 
1983.5 78.5 80.9 
    
82.30497 72.5 
 
1984.5 75.3 78.3 
    
77.64466 72.9 
 










69.04219 76.1 73.13 




65.07959 75.4 70.13 




61.32944 74.6 67.13 




57.78203 75 64.13 
1990.5 59.8 66.7 60.3 67 66.27417 
 
54.42791 71.8 60.64 

























1996.5 63.7 69.7 45.2 58 63.3033 66.1 54.27799 
 
70.13 
1997.5 67.2 72.2 40.3 60 65.23685 64.5 56.83656 
  
1998.5 71 74.4 36.9 63 67.34528 73.3 59.50816 
  
1999.5 74.7 76.2 35.7 65 69.73015 71.6 62.29703 
  
2000.5 77.9 77.8 36.1 67 71.8423 69.8 65.20755 
  
2001.5 80.5 79 38.1 68 73.3803 68.5 68.24415 
  
2002.5 81.6 80.1 42 69 74.32213 71.5 71.41136 
  
2003.5 82 81.2 46.8 70 74.0252 73.2 74.71376 
  
2004.5 81.4 80 51.6 70 72.52127 74.2 78.15604 
  
2005.5 79.9 77 55.7 69 68.98442 74.8 81.7429 
  
2006.5 75.8 76 57.3 68 64.91803 73.1 85.47911 
  




2008.5 65.6 73.7 55.3 67 55.13362 
    
2009.5 60.9 69.6 53.9 66 50.23082 
    
2010.5 56.6 66.1 52.3 65 49.03379 






















Year IGME IHME USCB Spectrum 
ASSA 







69.2 58.74 150.6 
 





61 67 56.35 146.9 
 





58 64.8 54.05 144.2 
 





56 62.6 51.87 142.3 
 





53 60.6 49.80 141 
 





50 58.5 47.89 139.8 
 





48 56.5 46.18 138.9 
 





46 54.7 44.80 137.3 
 





43 53 43.91 135.8 
 





41 51.4 43.70 133.2 
 
129 139.3 1998.2 
 
103.8 
1990.5 45.6 41.59 39 50 44.39 130.9 114.72 126 136.8 2002.4 
 
76.1 
1991.5 46.8 42.42 37 48.8 46.13 128.5 112.82 124 134.3 
   
1992.5 48.4 43.35 36 47.8 49.06 126.5 110.91 121 132 
   
1993.5 50.4 44.19 35 47.8 52.80 125 108.89 119 129.8 
   
1994.5 52.9 45.23 35 48.7 56.63 123.1 106.63 117 127.8 
   
1995.5 55.8 46.07 35 49.9 59.95 120.5 104.13 114 125.7 
   
1996.5 58.7 46.92 35 51.3 62.41 117.2 101.38 112 123.6 
   




1998.5 63.4 48.07 34 54.2 64.79 107.8 94.84 108 119.1 
   
1999.5 64 48.27 33 55.4 64.46 103.2 90.85 106 117 
   
2000.5 63.9 47.96 32 55.7 61.80 98.7 86.76 104 114.7 
   
2001.5 63.1 47.54 31 55.8 56.37 94.4 82.52 102 112.3 
   




2003.5 57.8 46.07 28 53.9 41.56 85.9 74.86 98 107.3 
   
2004.5 45.8 45.03 27 54 34.45 81.6 71.75 96 104.9 
   
2005.5 43 44.09 22 53.6 30.78 77.4 69.35 94 102.3 
   
2006.5 40 42.84 16 49.4 29.40 73.2 67.43 92 99.1 
   




2008.5 39 39.94 13 42.4 27.42 64.6 64.73 88 93.1 
   
2009.5 37.1 38.49 13 41.3 26.63 61.4 63.71 86 91.5 
   
2010.5 36.1 37.04 12 40.2 25.86 58.1 62.72 84 89.7 





















Year IGME IHME 
ASSA 
























    
1985.5 54.5 
 
53.37 56.6 56 
   
1986.5 52.6 
 
52.30 54.9 54 
   
1987.5 50.9 
 










49.19 51.3 48 
  
49.10 
1990.5 46.6 43.85 48.19 50.7 46 
  
46.61 
1991.5 45.5 42.92 47.18 50.1 44 
  
44.61 
1992.5 44.9 42.29 45.92 49.6 43 
  
43.10 
1993.5 45 41.35 45.14 49.6 42 
  
42.10 
1994.5 45.5 39.78 45.36 50.2 42 
  
43.10 
1995.5 46.6 37.19 45.74 51 42 
  
45.61 
1996.5 48 33.99 46.36 52.1 43 48.4 
 
48.10 
1997.5 49.8 30.51 47.45 53.4 45 47.5 46.6 51.10 
1998.5 51.5 27.96 48.34 54.4 46 53.2 52.7 
 
1999.5 53 27.04 49.24 55 47 51 51.1 
 
2000.5 54.3 27.35 49.74 55.3 48 48 49.9 
 
2001.5 55.1 28.87 49.69 55.6 48 45.2 49 
 
2002.5 54.9 31.74 49.22 55.7 48 46.6 50.1 
 
2003.5 54.8 35.13 47.99 55.6 48 46.6 51.2 
 
2004.5 54 38.33 46.50 53.7 48 45.8 49 
 
2005.5 52.9 40.93 44.17 52 47 48.2 49.5 
 
2006.5 49.2 41.97 41.32 52.6 46 47.8 50 
 




2008.5 45 40.72 36.35 50.9 45 
   
2009.5 42.5 39.78 33.00 48.4 44 
   
2010.5 40.7 38.75 32.40 46.6 44 


















Table B 3 Neonatal mortality rate for Botswana, Malawi and South Africa obtained from 
various sources 
 
Botswana Malawi South Africa 















1990.5 22.6 20.5 43.4 45.7 




1991.5 22.9 20.8 43 44.9 
    
18.6 15.4 
   





   
1993.5 24.5 21.4 42.1 43.6 
   
50.4 18.6 15.2 
   





   
1995.5 26.9 22.0 40.9 41.8 




1996.5 28.3 22.3 40.3 40.8 
    
19.5 13.5 
   




20.1 12.6 17.6 
  
1998.5 30.6 22.7 38.9 38.5 40 
  
50.4 20.7 12.0 18.6 
 
1995 




21.3 11.7 16.1 
 
1990 
2000.5 31.5 22.7 37.4 35.5 
    
21.8 11.7 15.6 15 
 
2001.5 31.5 22.5 36.6 34.0 
    
22.2 12.2 13.1 
  
2002.5 31 22.3 35.8 32.7 
    
22.4 12.9 14.3 
  
2003.5 30 22.0 34.9 31.5 36 
   
22.4 13.7 14.5 
  




22.3 14.5 13.3 
  
2005.5 24.2 21.4 33.3 29.7 
    
22 15.0 13.8 
  
2006.5 22.8 20.9 32.4 29.0 
    
21.3 15.3 14.1 
  
2007.5 22.4 20.5 31.5 28.5 
    
20.3 15.2 14.1 
  
2008.5 22.4 19.8 30.5 28.1 31 
   
19.5 15.0 
   
2009.5 21.8 19.5 29.7 27.7 
    
18.8 14.8 
     
 
